SlideShare uma empresa Scribd logo
1 de 38
Baixar para ler offline
Prevalence
Diabetes
in New York State
Adult
Diabetes Prevention and Control Program
Bureau of Chronic Disease Evaluation and Research
New York State Department of Health
ii
Authors:
Bureau of Chronic Disease Evaluation and Research
Rachael Ruberto, MPH, CPH, CHES
Ian Brissette, PhD
Bureau of Community Chronic Disease Prevention
Maureen Spence, MS, RD, CDN
Tracy Mills, MPP
For additional information about this report:
Rachael Ruberto, MPH, CPH, CHES
Bureau of Chronic Disease Evaluation and Research
Division of Chronic Disease Prevention
New York State Department of Health
Empire State Plaza
Corning Tower, Room 565
Albany, NY 12237
518-474-2434
rxr24@health.state.ny.us
For additional information about the Diabetes
Prevention and Control Program:
Maureen Spence, MS, RD, CDN
Director, Diabetes Prevention and Control Program
Bureau of Community Chronic Disease Prevention
Division of Chronic Disease Prevention
New York State Department of Health
Riverview Center
150 Broadway, 3rd Floor West
Albany, NY 12204
518-408-0125
mms07@health.state.ny.us
This report was supported by Cooperative Agreement
Number 1U58/DP00-1963-03 from the National Center
for Chronic Disease Prevention and Health Promotion,
United States Centers for Disease Control and Prevention
(CDC). Its contents are solely the responsibility of the
authors and do not necessarily represent the official view
of the CDC.
iii
Table of Contents
Executive Summary .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . iv
List of Figures .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . v
List of Tables  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . vi
Diabetes Overview  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 1
Surveillance Indicators and Data Sources .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 3
Data Standards and Objectives  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 5
Diagnosed Diabetes  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 7
Undiagnosed Diabetes .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 19
Prediabetes  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 23
Gestational Diabetes  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 27
References .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 30
iv
Executive Summary
Adult Diabetes Prevalence in New York State examines data on the prevalence of diagnosed and
undiagnosed diabetes, prediabetes, and gestational diabetes among New York State (NYS) adults.
Using the NYS Behavioral Risk Factor Surveillance System (BRFSS), NYS Vital Statistics, and the Centers
for Disease Control and Prevention’s Wide-ranging Online Data for Epidemiologic Research (CDC
WONDER) as data sources, the report summarizes information about the prevalence of diabetes by year
and selected demographic characteristics, including age, gender, race/ethnicity, household income,
educational attainment, and region. This Executive Summary offers highlights of the diabetes-related
information in New York State detailed throughout the report.
•	 The prevalence of self-reported diabetes
among adults in NYS has increased steadily
over the past 11 years. The three-year moving
average has nearly doubled from 4.6% in
1996-1998 to 8.5% in 2007-2009.
•	 The risk of diabetes increases with age.
•	 Diabetes is most prevalent among adults
between the ages of 65-74 years (20.3%).
•	 Self-reported diabetes is more prevalent
among non-Hispanic blacks (12.1%) than
among non-Hispanic whites (7.7%).
•	 Although the majority of adults with diabetes
living in NYS are non-Hispanic whites, racial/
ethnic minorities make up a larger proportion
of the population of adults with diabetes
(44%) than the total NYS population (32%).
•	 Adults with an annual household income
less than $15,000 are nearly three times as
likely to report having diabetes as adults with
an annual household income of more than
$50,000 (15.2% versus 5.2%).
•	 Approximately two-thirds of adults living
with diabetes (66%) reside outside of New
York City.
•	 National estimates from 2005-2006 indicate
that 5.1% of adults above the age of 20 had
undiagnosed diabetes.1
These estimates can
be applied to give a general estimate of the
prevalence of undiagnosed diabetes in the
NYS population (760,000 adults above the age
of 20).
•	 Testing for high blood sugar is less prevalent
among adults without health insurance
compared to adults who report having health
insurance (42% versus 62%) and among
adults without a regular healthcare provider
compared to adults with a regular healthcare
provider (38% versus 64%).
•	 Prediabetes is more prevalent among
adults who are obese (10.7%) or overweight
(5.3%) than among adults who are neither
overweight nor obese (2.9%).
•	 The prevalence of gestational diabetes in NYS
has steadily increased from 1995 (35.5 per
1,000 live births) to 2006 (47.3 per 1,000 live
births). In NYS, the prevalence of gestational
diabetes is highest among Asian women
(7.9%).
v
List of Figures
Figure 1. 	 Prevalence of diabetes among New York State (NYS) adults,
BRFSS 1996-2009 .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  7
Figure 2.	 Prevalence of diabetes among New York State (NYS) adults by age,
BRFSS 2007-2009 .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  9
Figure 3.	 Age distribution of New York State (NYS) adults with diabetes,
BRFSS 2007-2009 .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .10
Figure 4.	 Prevalence of diabetes among New York State (NYS) adults
by gender, BRFSS 2007-2009  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 11
Figure 5.	 Prevalence of diabetes among New York State (NYS) adults
by age and gender, BRFSS 2007-2009  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .12
Figure 6.	 Prevalence of diabetes among New York State (NYS) adults
by race/ethnicity, BRFSS 2007-2009  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 13
Figure 7.	 Race/ethnicity of New York State (NYS) adults with diabetes,
BRFSS 2007-2009 .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .14
Figure 8.	 Prevalence of diabetes among New York State (NYS) adults
by annual household income level, BRFSS 2007-2009 .  .  .  .  .  .  .  .  .  .  .  .15
Figure 9.	 Prevalence of diabetes among New York State (NYS) adults
by education level, BRFSS 2007-2009  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .16
Figure 10.	 Prevalence of diabetes among New York State (NYS) adults
by region, BRFSS 2007-2009  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .17
Figure 11.	 Regional distribution of New York State (NYS) adults with diabetes,
BRFSS 2007-2009 .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .18
Figure 12.	 Percentage of adults in New York State (NYS) receiving a test
for high blood sugar or diabetes in the past three years by age,
BRFSS 2008-2009 .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .21
Figure 13.	 Percentage of adults in New York State (NYS) receiving a test
for high blood sugar or diabetes in the past three years
by access to care indicators, BRFSS 2008-2009   .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  22
Figure 14.	 Prevalence of prediabetes among New York State (NYS) adults
by age, BRFSS 2008-2009 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Figure 15.	 Prevalence of prediabetes among New York State (NYS) adults
by race/ethnicity, BRFSS 2008-2009  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  25
Figure 16.	 Prevalence of prediabetes among New York State (NYS) adults
by Body Mass Index (BMI) category, BRFSS 2008-2009   .  .  .  .  .  .  .  .  .  .  26
Figure 17.	 Prevalence of gestational diabetes in the United States (US)
and New York State (NYS), CDC WONDER 1995-2006   .  .  .  .  .  .  .  .  .  .  .  28
Figure 18.	 Prevalence of gestational diabetes in New York State (NYS)
by race/ethnicity of mother, NYSDOH Biometrics, 2007  .  .  .  .  .  .  .  .  .  . 29
vi
List of Tables
Table 1.	 Prevalence of diabetes among New York State (NYS) adults,
BRFSS 1996-2009  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  8
Table 2.	 Percentage of adults in New York State (NYS) receiving a test
for high blood sugar or diabetes in the past three years
by selected demographic characteristics, BRFSS 2008-2009 .  .  .  .  .  .  .  20
1
Diabetes Overview
Diabetes is a disease in which blood sugar (glucose) levels are above normal.2
Glucose, a form of sugar
created from digestion of food, is used by the body for energy with the help of a hormone known as
insulin. In people with diabetes, glucose cannot easily be used by the cells of the body because of a
problem with insulin. This leads to high levels of glucose in the blood, sometimes referred to as high
blood sugar or hyperglycemia.
Types of Diabetes
The difference between various types of diabetes is based mostly on the specific problem occurring
with the hormone, insulin. Insulin is made by and released from the pancreas, an organ that sits behind
the stomach. In some types of diabetes, the cells that make insulin are damaged, which leads to an
inability to produce insulin. In other types of diabetes, insulin is produced by the pancreas, but other
tissues of the body do not recognize it. Both types lead to high blood glucose. The following table
highlights the most common types of diabetes:3,4
Type Description
Type 1 Diabetes •	Cells in the pancreas are damaged leading to a decreased
release of insulin.
• 	Cell damage usually leads to a total lack of insulin
production.
Type 2 Diabetes • 	Insulin is not used properly by the body, so glucose is not
absorbed.
• 	There may be a problem with insulin being secreted by the
pancreas.
Gestational
Diabetes
• 	Diabetes develops during pregnancy.
• 	Diabetes often resolves after delivery, although these
women are at increased risk for development of type 2
diabetes in the future.
Prediabetes •	The blood glucose level is high, but not high enough to
meet the criteria for diabetes.
• 	Prediabetes is a risk factor for future diabetes.
2
Diagnosing and Classifying Diabetes and Prediabetes
Diabetes can be diagnosed in any one of four ways.5, 6
1.	Hemoglobin A1C test (A1C)
a non-fasting blood test that measures the amount of glucose attached to hemoglobin. This test is
used to assess blood glucose control over the previous 2-3 months, and has recently been added to
the list of tests that may be used to diagnose diabetes.
2.	Fasting plasma glucose test (FPG)
a blood test that measures glucose after a person has not eaten for at least 8 hours.
3.	Oral glucose tolerance test (OGTT)
a blood test that measures glucose after a person has not eaten for 8 hours and 2 hours after that
person has consumed a glucose-containing drink.
4.	Random plasma glucose test (RPG)
a blood test that measures glucose which doesn’t require a person to fast prior to the test. RPG
is only used as a diagnostic criterion for diabetes when the patient has classic symptoms of
hyperglycemia or hyperglycemic crisis.
The results of any of the above tests can be used to determine whether diabetes or prediabetes is
present. Positive tests should be repeated on a different day to be sure the above results are correct.
DIABETES
≥ 6.5%
< 6.4%
≥ 5.7%
< 5.7%
PRE-DIABETES
NORMAL
DIABETES
≥ 126 mg/dl
< 126 mg/dl
≥ 100 mg/dl
< 100 mg/dl
PRE-DIABETES
NORMAL
DIABETES
≥ 200 mg/dl
< 200 mg/dl
≥ 140 mg/dl
< 140 mg/dl
PRE-DIABETES
NORMAL
A1C FPG OGTT
3
Surveillance Indicators and Data Sources
Diagnosed diabetes
The Behavioral Risk Factor Surveillance System (BRFSS) is used to assess and track the prevalence
of diabetes in adults. The BRFSS is a statewide random-digit-dialing telephone survey of the non-
institutionalized adult population aged 18 years and older. The annual NYS BRFSS survey includes a
question assessing whether the survey respondent had been diagnosed with diabetes (Have you ever
been told by a doctor that you have diabetes?) and a follow-up question to exclude women who may
have had gestational diabetes (Was this only when you were pregnant?). Data obtained from these
questions can be used to estimate the prevalence of diagnosed diabetes in the adult population. The
questions cannot distinguish between adults with Type I and Type II diabetes. More information about
the BRFSS survey method is available on the BRFSS page on the New York State Department of Health
(NYSDOH) website. http://www.nyhealth.gov/nysdoh/brfss/
Three successive years of BRFSS data were combined to calculate the weighted estimates of the
prevalence of diagnosed diabetes in NYS. These prevalence estimates are more stable than those
based on a single year of data and provide an adequate sample for subgroup comparisons. The 95%
confidence intervals (CIs) for these estimates are provided in data tables reported, but are not included
in the figures.
Undiagnosed diabetes
To conduct public health surveillance on undiagnosed diabetes in New York State would require
routinely conducting a state specific survey in which the determination of whether an individual has
diabetes is based on appropriate clinical diagnostic tests and not self-report.
There is currently no data source in New York State for conducting surveillance on undiagnosed
diabetes. However, the NYS BRFSS provides information on the proportion of adults who receive the
appropriate diagnostic test for diabetes. In 2008 and 2009, the NYS BRFSS survey included a question
for assessing screening for diabetes in the past three years (Have you had a test for high blood sugar or
diabetes within the past three years?) Two successive years of BRFSS data were combined to calculate
the weighted estimates of the prevalence of testing for high blood sugar or diabetes within the past
three years.
Prediabetes
The NYS BRFSS is also used to assess and track the prevalence of diagnosed prediabetes in adults. In
2008 and 2009, the BRFSS survey included questions for assessing screening for diabetes in the past
three years (Have you had a test for high blood sugar or diabetes within the past three years?) and
physician diagnosis of prediabetes (Have you ever been told by a doctor or other health professional
that you have prediabetes or borderline diabetes?). Data from these two questions in the 2008 and
2009 BRFSS were combined to calculate the weighted estimates of the prevalence of self-reported
prediabetes.
Gestational diabetes
Data from several sources were used to document the gestational diabetes (GDM) prevalence. Public-
use natality (live birth) data maintained through the National Center for Health Statistics (NCHS) were
obtained via the CDC WONDER online database and used to compare changes in rates of gestational
diabetes in the US and New York State. The dataset includes counts of births occurring within the
United States to US residents and non-residents between 1995 and 2006. State and county are
defined by the mother’s place of residence recorded on the birth certificate. Data elements include
demographics, medical risk factors and maternal tobacco use.7
Rates of gestational diabetes for New
York State and the US are calculated as the number of singleton births to women where maternal
4
diabetes was reported as a risk factor on the birth certificate. All rates are expressed per 1,000
live births.
Vital statistics data from the New York State Bureau of Biometrics and Health Statistics were used to
examine differences in the prevalence of GDM in New York State by race/ethnicity. The prevalence of
gestational diabetes was calculated for each category of maternal race as the number of live births to
women with gestational diabetes divided by the total births in New York State for 2007.
For more information on any of the gestational diabetes data sources detailed above, please visit the
following links:
http://wonder.cdc.gov/natality.html
http://www.nyhealth.gov/nysdoh/vital_statistics/
5
Data Standards and Objectives
NYS Department of Health Prevention Agenda Toward the Healthiest State
In 2008, the New York State Department of Health (NYSDOH) launched a Prevention Agenda Toward
the Healthiest State to support the goals of health care reform. This agenda established ten statewide
public health priorities and called upon local health departments, hospitals and other community
partners to work together to address them. The emphasis of this public health initiative is on
prevention strategies to improve the health of all New Yorkers and foster healthy communities.
The Prevention Agenda established a goal of reducing the prevalence of diagnosed diabetes, as
assessed using the BRFSS, to 5.7% by 2013.
More information about the NYSDOH Prevention Agenda is available on the Prevention Agenda page
on the NYSDOH website. http://nyhealth.gov/prevention/prevention_agenda/index.htm
Healthy People 2020
Healthy People 2020 (HP2020) are a comprehensive set of disease prevention and health promotion
objectives for the Nation to achieve over the next ten years. HP2020 established objectives aimed
at reducing the economic burden of diabetes, and improving the quality of life for all persons who
have or are at risk for diabetes. These objectives include a target related to increasing the proportion
of adults aged 20 and older with diabetes whose condition has been diagnosed (objective #D-15), as
assessed using the National Health and Nutrition Examination Survey (NHANES), from 72.8% in 2005-
2008 to 80.1% in 2020. Although there is not a NYS-specific data set for tracking the HP2020 objective,
data from the NYS BRFSS on the percentage of adults receiving a blood glucose test for diabetes can
serve to assess progress toward reducing undiagnosed diabetes in NYS.
For more information about HP2020, please use the following link:
http://www.healthypeople.gov/2020/default.aspx
6
5
10
15
New York State New York State Prevention Agenda 2013 Target
0
1997-1999 1999-2001 2001-2003 2003-2005 2005-2007 2007-2009
5.7
7
Diagnosed Diabetes
Figure 1. Prevalence of diabetes among New York State (NYS) adults, BRFSS 1996-2009
The prevalence of self-reported diabetes among adults in NYS has increased steadily
over the past 11 years. The three-year moving average has nearly doubled from 4.6% in
1996-1998 to 8.5% in 2007-2009.
The Centers for Disease Control and Prevention indicate that 8.3% of adults in the US
report being diagnosed with diabetes (US BRFSS, 2006-2008). This is comparable to the
8.5% estimated in NYS.
The current self-reported prevalence of diabetes in NYS (8.5%) is well above the objective
identified in the Prevention Agenda (5.7%). For more information on the NYSDOH
Prevention Agenda Toward the Healthiest State, please visit: http://www.nyhealth.gov/
prevention/prevention_agenda/
8
Table 1. Prevalence of diabetes among New York State (NYS) adults, BRFSS 1996-2009
Year Percent Lower 95% CI† Upper 95% CI†
Prevention Agenda Target* 5.7% - -
1996-1998** 4.6 4.1 5.1
1997-1999 5.4 4.9 6.0
1998-2000 6.0 5.4 6.6
1999-2001 6.3 5.7 6.8
2000-2002 6.8 6.2 7.3
2001-2003 7.1 6.6 7.7
2002-2004 7.4 6.9 7.9
2003-2005 7.7 7.3 8.2
2004-2006 7.8 7.3 8.3
2005-2007 8.0 7.5 8.4
2006-2008 8.1 7.7 8.5
2007-2009 8.5 8.0 8.9
*The Prevention Agenda Target of 5.7% was established in 2008.
**In 1997, the diagnostic criteria recommended for diagnosing diabetes changed to include
a lower cut-point for fasting plasma glucose values used to classify someone as having
Type 2 diabetes.
†CI = confidence interval.
2.2
12.0
20.3
19.0
0
5
10
15
20
25
18 - 44 yrs 45 - 64 yrs 65 - 74 yrs 75 yrs or older
Percent
9
Figure 2.	 Prevalence of diabetes among New York State (NYS) adults by age, BRFSS 2007-2009
Age Group Percent Lower 95% CI Upper 95% CI
18-44 yrs 2.2 1.7 2.6
45-64 yrs 12.0 11.1 12.9
65-74 yrs 20.3 18.6 22.1
75 yrs or older 19.0 17.2 20.8
The risk of diabetes increases with age. The prevalence of diabetes is highest among
adults between the ages of 65-74 years (20.3%).
Diabetes is over 5 times more prevalent among adults between the ages of 45 and 64 years
(12.0%) than among adults aged 18 to 44 years (2.2%).
18 - 44 years
45 - 64 years
65 - 74 years
75 years or older
12.5%
18.2%
22.6%
46.7%
10
Figure 3.	 Age distribution of New York State (NYS) adults with diabetes, BRFSS 2007-2009
Age Group Percent Lower 95% CI Upper 95% CI
18-44 yrs 12.5 10.2 14.8
45-64 yrs 46.7 44.0 49.4
65-74 yrs 22.6 20.6 24.6
75 yrs or older 18.2 16.4 20.0
Adults between the ages of 45 and 64 years represent almost one-half (46.7%) of the
adults living with diabetes in NYS.
Male Female
8.1
8.9
0
2
4
6
8
10
Percent
11
Figure 4.	 Prevalence of diabetes among New York State (NYS) adults by gender, BRFSS 2007-2009
Gender Percent Lower 95% CI Upper 95% CI
Male 8.9 8.2 9.6
Female 8.1 7.5 8.7
The prevalence of diabetes in NYS does not differ statistically among males and females.
Male Female
18-44 yrs 45-64 yrs 65-74 yrs 75 yrs or older
17.718.3
10.6
2.2
21.2
22.8
13.5
2.1
0
5
10
15
20
25
Percent
12
Figure 5.	 Prevalence of diabetes among New York State (NYS) adults by age and gender,
BRFSS 2007-2009
Gender Percent Lower 95% CI Upper 95% CI
Male
18-44 yrs 2.1 1.5 2.7
45-64 yrs 13.5 12.0 15.0
65-74 yrs 22.8 20.0 25.7
75 yrs or older 21.2 18.1 24.3
Female
18-44 yrs 2.2 1.6 2.8
45-64 yrs 10.6 9.5 11.7
65-74 yrs 18.3 16.2 20.4
75 yrs or older 17.7 15.5 19.8
Diabetes prevalence increases with age among both men and women.
Non-Hispanic white Non-Hispanic black Hispanic Non-Hispanic Asian
5.7
8.3
12.1
7.7
0
5
10
15
Percent
13
Figure 6.	 Prevalence of diabetes among New York State (NYS) adults by race/ethnicity,
BRFSS 2007-2009
Race/Ethnicity Percent Lower 95% CI Upper 95% CI
Non-Hispanic white 7.7 7.3 8.2
Non-Hispanic black 12.1 10.5 13.8
Hispanic 8.3 6.9 9.8
Non-Hispanic Asian 5.7 3.6 7.9
Self-reported diabetes is more prevalent among non-Hispanic blacks (12.1%) than among
non-Hispanic whites (7.7%).
Non-Hispanic white
Non-Hispanic black
Hispanic
Non-Hispanic Asian
Non-Hispanic other
5.8%
3.4%
15.6%
19.8%
55.3%
14
Figure 7.	 Race/ethnicity of New York State (NYS) adults with diabetes, BRFSS 2007-2009
Race/Ethnicity Percent Lower 95% CI Upper 95% CI
Non-Hispanic white 55.3 52.5 58.2
Non-Hispanic black 19.8 17.4 22.2
Hispanic 15.6 13.2 18.1
Non-Hispanic Asian 3.4 2.1 4.7
Non-Hispanic other 5.8 4.3 7.3
Although the majority of adults with diabetes living in NYS are non-Hispanic whites (55%),
racial/ethnic minorities make up a larger proportion of the population of adults with
diabetes (45%) than the total population (32%).
<$15,000
15.2
$15-24,999
12.5
$25-34,999
9.9
$35-49,999
9.3
$50,000 or more
5.2
0
5
10
20
Percent
15
15
Figure 8.	 Prevalence of diabetes among New York State (NYS) adults by annual household
income level, BRFSS 2007-2009
Annual Income Percent Lower 95% CI Upper 95% CI
<$15,000 15.2 13.2 17.3
$15-24,999 12.5 11.0 14.0
$25-34,999 9.9 8.3 11.6
$35-49,999 9.3 7.9 10.7
$50,000 or more 5.2 4.7 5.8
Adults with an annual household income of less than $15,000 are almost three times as
likely to report having diabetes as adults with an annual household income of more than
$50,000 (15.2% versus 5.2%).
16
Figure 9.	 Prevalence of diabetes among New York State (NYS) adults by education level,
BRFSS 2007-2009
Education Percent Lower 95% CI Upper 95% CI
<High school 13.0 11.1 15.0
High school or general
equivalency diploma
11.0 10.0 12.0
Some post high school 8.5 7.7 9.4
College graduate 5.4 4.8 5.9
Adults with less than a high school education are more than twice as likely to report
having diabetes as adults who are college graduates (13.0% versus 5.4%).
The prevalence of diabetes becomes increasingly greater among segments of the
population that are lower in educational attainment and household income.
<High school
13.0
High school or
General Equivalency
Diploma (GED)
11.0
Some post high school
8.5
College graduate
5.4
0
5
10
15
Percent
New York State (excluding NYC)
8.4
New York City
8.7
0
2
4
6
8
10
Percent
17
Figure 10.	 Prevalence of diabetes among New York State (NYS) adults by region, BRFSS 2007-2009
Region Percent Lower 95% CI Upper 95% CI
New York City 8.7 7.8 9.6
New York State (excluding New York City) 8.4 7.9 8.9
The prevalence of diabetes among adults residing in New York State (excluding New York
City) does not differ statistically from the prevalence of diabetes among adults in New
York City.
County level data on the prevalence of diabetes in NYS can be found at the website:
http://www.nyhealth.gov/statistics/brfss/expanded/
Data on the prevalence of diabetes collected through the New York City Department of
Health and Mental Hygiene can be obtained at the website: http://www.nyc.gov/html/doh/
downloads/pdf/epi/diabetes_chart_book.pdf
New York City
New York State
(excluding New York City)
65.6%
34.4%
18
Figure 11.	 Regional distribution of New York State (NYS) adults with diabetes, BRFSS 2007-2009
Region Percent Lower 95% CI Upper 95% CI
New York City 34.4 31.7 37.2
New York State (excluding New York City) 65.6 62.8 68.3
Approximately two-thirds of NYS adults living with diabetes (66%) reside outside of
New York City.
19
Undiagnosed Diabetes
The prevalence of adult diabetes in the New York State population includes instances where diabetes
is diagnosed by a medical care professional and instances where it has not yet been detected. The
previous section of the report summarized data on the percentage of adults with diagnosed diabetes.
This represents only a portion of adults living with this chronic disease. Diabetes can go undetected
among those who do not receive medical care or do not receive the appropriate diagnostic tests from
their medical care providers.
In New York State there is no system for conducting public health surveillance on undiagnosed
diabetes. Data from the National Health and Nutrition Examination Survey (NHANES), a survey
designed to enroll a representative sample of the US civilian population, estimate that in 2005-2006,
5.1% of adults above the age of 20 had undiagnosed diabetes.8
These national estimates can be applied
to give a general estimate of the prevalence of undiagnosed diabetes in the New York State population
(760,000 adults). However, this estimate does not take into consideration how the population of New
York adults differs from adults in the rest of the US population or how rates of diagnostic testing for
diabetes differ in New York as compared to other States.
For more information about the NHANES, please use the following link:
http://www.cdc.gov/nchs/nhanes.htm
Reducing undiagnosed diabetes is a priority in diabetes prevention and control. Healthy People 2020
includes an objective to increase the percentage of adults with diabetes whose condition has been
diagnosed. As described on page 4 of this report, diabetes is diagnosed though blood tests that
measure the amount of glucose in the blood. The NYS BRFSS provides information on the proportion
of adults who receive the appropriate diagnostic test for diabetes within the past three years.
20
Table 2.	 Percentage of adults in New York State (NYS) receiving a test for high blood sugar
or diabetes in the past three years by selected demographic characteristics,
BRFSS 2008-2009
Percent Lower 95% CI Upper 95% CI
Age Group
All ages 59.8 58.2 61.4
18-44 50.8 48.1 53.5
45-64 68.1 66.0 70.1
65-74 74.7 71.6 77.8
≥75 68.8 65.2 72.4
Gender
Male 58.2 55.5 60.8
Female 61.2 59.3 63.1
Race/Ethnicity
Non-Hispanic white 60.5 58.8 62.2
Non-Hispanic black 56.5 50.3 62.8
Hispanic 58.8 52.4 65.1
Non-Hispanic other 54.7 47.5 61.9
Annual Income
<$15,000 57.5 51.0 63.9
$15-24,999 59.5 54.4 64.5
$25-34,999 56.6 51.1 62.1
$35-49,999 56.2 51.6 60.7
$50,000 or more 63.4 61.2 65.6
Education
<High school 55.4 48.3 62.5
High school or general
equivalency diploma
56.7 53.4 59.9
Some post high school 60.6 57.4 63.8
College graduate 62.3 60.0 64.6
Region
New York City 60.2 56.8 63.5
NYS (excluding New York City) 59.6 57.8 61.4
In 2008-2009, the self-reported prevalence for having a test for high blood sugar or
diabetes in the past three years was 59.8% (95% CI 58.2-61.4%) among NYS adults.
The percentage of adults in NYS receiving a test for high blood sugar or diabetes in the
past three years does not differ significantly by gender, race/ethnicity, household income,
education, or region (New York City vs. rest of state).
18-44 yrs
50.8
45-64 yrs
68.1
65-74 yrs
74.7
75 yrs or older
68.8
All ages
59.8
0
20
40
80
Percent
60
30
50
70
10
21
Figure 12.	 Percentage of adults in New York State (NYS) receiving a test for high blood sugar or
diabetes in the past three years by age, BRFSS 2008-2009
The prevalence of testing for high blood sugar in the past three years is lowest among
adults between the ages of 18 to 44 years.
Health insurance
62.1
41.5
Regular provider
63.5
37.5
Yes No
0
20
40
60
70
80
Percent
10
30
50
22
Figure 13.	 Percentage of adults in New York State (NYS) receiving a test for high blood sugar or
diabetes in the past three years by access to care indicators, BRFSS 2008-2009
Percent Lower 95% CI Upper 95% CI
Insurance Status
Have insurance 62.1 60.4 63.7
No insurance 41.5 35.7 47.3
Provider Status
Have regular provider 63.5 61.8 65.1
No regular provider 37.5 32.7 42.4
Testing for high blood sugar is less prevalent among adults without health insurance
compared to adults who report having health insurance (42% versus 62%) and among
adults without a regular healthcare provider compared to adults who report having at
least one regular healthcare provider (38% versus 64%).
23
Prediabetes
Prediabetes is a condition in which an individual’s blood glucose levels are higher than normal, but
not high enough to be diagnosed as diabetes. Like diabetes, prediabetes is detected by means of a
blood glucose test. The clinical cut-offs for classification depend on the type of diagnostic test used.
The values of these clinical tests that are used to diagnose prediabetes can be found on page 4 of this
report.
In the United States, an estimated 35% of adults aged 20 or older have prediabetes.9
Adults with
prediabetes are 5 to 15 times more likely to develop type 2 diabetes than someone without the
condition, and are also at increased risk of developing heart disease, stroke and eye disease.10
Lifestyle
intervention programs aimed at increasing physical activity and producing a 5–7% loss of body weight,
and certain pharmacological agents have been demonstrated to prevent or delay the development of
diabetes in people with prediabetes.11
18-44 yrs
3.4
45-64 yrs
7.5
65-74 yrs
9.4
75 yrs or older
6.4
All ages
5.5
0
15
Percent
5
10
24
Figure 14.	 Prevalence of prediabetes among New York State (NYS) adults by age, BRFSS 2008-2009
Age (years) Percent Lower 95% CI Upper 95% CI
18-44 yrs 3.4 2.5 4.3
45-64 yrs 7.5 6.3 8.6
65-74 yrs 9.4 7.4 11.4
75 yrs or older 6.4 4.7 8.1
All ages 5.5 4.8 6.1
Prediabetes is less prevalent among adults between the ages of 18 and 44 years (3.4%)
than among adults between the ages of 45 to 64 years (7.5%), 65 to 74 years (9.4%), and
75 years or older (6.4%).
Non-Hispanic white
5.4
Non-Hispanic black
8.1
Hispanic
3.9
0
8
10
Percent
6
4
2
25
Figure 15.	 Prevalence of prediabetes among New York State (NYS) adults by race/ethnicity, BRFSS
2008-2009
Race/Ethnicity Percent Lower 95% CI Upper 95% CI
Non-Hispanic white 5.4 4.7 6.1
Non-Hispanic black 8.1 4.8 11.4
Hispanic 3.9 2.1 5.8
Self-reported prediabetes does not differ significantly by race/ethnicity.
<25
(Neither overweight nor obese)
2.9
25-<30
(Overweight)
5.3
≥30
(Obese)
10.7
0
10
15
Percent
5
26
Figure 16.	 Prevalence of prediabetes among New York State (NYS) adults by Body Mass Index (BMI)
category, BRFSS 2008-2009
BMI Category Percent Lower 95% CI Upper 95% CI
<25 (Neither overweight nor obese) 2.9 2.1 3.8
25-<30 (Overweight) 5.3 4.3 6.3
≥30 (Obese) 10.7 8.8 12.6
Prediabetes is more prevalent among adults who are obese (10.7%) or overweight (5.3%)
than among adults who are neither overweight nor obese (2.9%).
27
Gestational Diabetes
Gestational diabetes (GDM) is defined as any degree of glucose intolerance with onset or first
recognition during pregnancy. Based on this definition, GDM affects approximately 7% of pregnancies
in the United States (ranging from 1%-14% depending on the population studied), resulting in
approximately 200,000 cases annually.12
Gestational diabetes predisposes women to an increased
risk of developing type 2 diabetes later in life, and has been associated with both maternal and fetal
adverse health effects including macrosomia, preeclampsia, congenital malformations, and fetal
death.13
Because of the health risks gestational diabetes confers to both the mother and infant, public
health surveillance of GDM is warranted.
Rateper1,000livebirths*
10
30
50
20
40
0
1995 1997 2000 2002 2004 2006
United States New York State
1996 1998 2001 2003 20051998
15
35
25
45
5
28
Figure 17.	 Prevalence of gestational diabetes in the United States (US) and New York State (NYS),
CDC WONDER 1995-200614
Year US Rate New York State Rate
1995 24.7 35.5
1996 25.7 39.5
1997 25.8 40.4
1998 26.0 40.1
1999 26.6 38.4
2000 28.6 42.6
2001 30.5 44.9
2002 32.1 45.0
2003 32.2 43.4
2004 35.1 44.0
2005 37.8 44.1
2006 41.6 47.3
*Based on singleton births, birth certificate change in 2003.
More information about this change is available at:
http://wonder.cdc.gov/natality.html
The prevalence of gestational diabetes in the US and in NYS has gradually increased from
1995 to 2006.
The prevalence of gestational diabetes is higher among women in NYS compared to the US
overall.
Non-Hispanic white
3.8
Non-Hispanic black
4.2
Hispanic
4.1
Non-Hispanic Asian
7.9
Non-Hispanic other
5.0
0
10
Percent
4
6
2
8
29
Figure 18.	 Prevalence of gestational diabetes in New York State (NYS) by race/ethnicity of mother,
NYSDOH Biometrics, 2007
Race/Ethnicity of Mother Percent**
Non-Hispanic white 3.8
Non-Hispanic black 4.2
Hispanic 4.1
Non-Hispanic Asian 7.9
Non-Hispanic other 5.0
**No confidence intervals are provided for population-level data
In NYS, the prevalence of gestational diabetes is highest among Asian women.
30
References
1	 Cowie CC, Rust KF, Fored ES, Eberhardt MS,
Dyrd-Holt DD, Li C, Williams DE, Gregg EW,
Bainbridge KE, Saydah SH, Geiss LS. Full
accounting of diabetes and pre-diabetes in
the US population in 1988-1994 and 2005-
2006. Diabetes Care. February 2009;32(2):287-
294.
2	 National Institute of Diabetes and Kidney
Diseases, National Institutes of Health.
Diagnosis of Diabetes, National Diabetes
Clearinghouse [cited 2010 Dec 2]. Available
at: http://diabetes.niddk.nih.gov/dm/pubs/
diagnosis.
3	 American Diabetes Association. Diagnosis
and classification of diabetes mellitus.
Diabetes Care. 2011;34(S1):S62-S69.
4	 National Diabetes Education Program.
Overview of diabetes in children and
adolescents. Available at: http://ndep.nih.
gov/diabetes/pubs/ Youth_FactSheet.pdf.
5	 American Diabetes Association. Diagnosis
and classification of diabetes mellitus.
Diabetes Care. 2011;34(S1):S62-S69.
6	 National Institute of Diabetes and Kidney
Diseases, National Institutes of Health.
Diagnosis of Diabetes, National Diabetes
Clearinghouse [cited 2010 Jul 19]. Available
at: http://diabetes.niddk.nih.gov/dm/pubs/
diagnosis.
7	 Centers for Disease Control and Prevention.
CDC Wonder Natality Online Database [cited
2010 Jul 19]. Available at http://wonder.cdc.
gov/natality.html.
8	 Cowie CC, Rust KF, Fored ES, Eberhardt MS,
Dyrd-Holt DD, Li C, Williams DE, Gregg EW,
Bainbridge KE, Saydah SH, Geiss LS. Full
Accounting of Diabetes and Pre-Diabetes in
the US Population in 1988-1994 and 2005-
2006. Diabetes Care. February 2009;32(2):287-
294.
9	 Centers for Disease Control and Prevention.
National diabetes fact sheet: national
estimates and general information on
diabetes and prediabetes in the United
States, 2011. Atlanta, GA: US Department
of Health and Human Services, Centers for
Disease Control and Prevention, 2011.
10	 Cited in Centers for Disease Control
and Prevention, Diabetes Public Health
Resources. Frequently Asked Questions
about Pre-Diabetes [cited 2009 Jun 1].
Available at: http://www.cdc.gov/diabetes/
faq/prediabetes.htm.
11	 American Diabetes Association. Diagnosis
and classification of diabetes mellitus.
Diabetes Care. 2011;34(S1):S62-S69.
12	 American Diabetes Association. Standards
of medical care in diabetes. – 2011. Diabetes
Care. 2011:34(S1):S11-S61.
13	 Vincor, F. Diabetes & women’s health across
the life stages: A public health perspective.
Atlanta, GA: US Department of Health and
Human Services, Centers for Disease Control
and Prevention, 2001 [cited 2010 Feb 19].
Available at: http://www.cdc.gov/diabetes/
pubs/pdf/womenshort.pdf
14	 United States Department of Health and
Human Services (US DHHS), Centers for
Disease Control and Prevention (CDC),
National Center for Health Statistics (NCHS),
Division of Vital Statistics, Natality public-use
data 1995-2006, on CDC WONDER Online
Database, March 2009 [cited 2009 Dec 23].
Available at: http://wonder.cdc.gov/natality-
current.html.
State of New York
Department of Health
	10/11

Mais conteúdo relacionado

Destaque

Global Medical Cures™ | Womens Health- VIOLENCE AGAINST WOMEN
Global Medical Cures™ | Womens Health- VIOLENCE AGAINST WOMENGlobal Medical Cures™ | Womens Health- VIOLENCE AGAINST WOMEN
Global Medical Cures™ | Womens Health- VIOLENCE AGAINST WOMENGlobal Medical Cures™
 
Configuration Manager: zero-touch & Windows 8.1 (MS NetWork 4)
Configuration Manager: zero-touch & Windows 8.1 (MS NetWork 4)Configuration Manager: zero-touch & Windows 8.1 (MS NetWork 4)
Configuration Manager: zero-touch & Windows 8.1 (MS NetWork 4)Tomica Kaniski
 
Global Medical Cures™ | Medicines for Treating Mental Health Conditions
Global Medical Cures™ | Medicines for Treating Mental Health ConditionsGlobal Medical Cures™ | Medicines for Treating Mental Health Conditions
Global Medical Cures™ | Medicines for Treating Mental Health ConditionsGlobal Medical Cures™
 
Global Medical Cures™ | STROKE- Challenges, Progress & Promise
Global Medical Cures™ | STROKE- Challenges, Progress & PromiseGlobal Medical Cures™ | STROKE- Challenges, Progress & Promise
Global Medical Cures™ | STROKE- Challenges, Progress & PromiseGlobal Medical Cures™
 
Global Medical Cures™ | AGING- SAMPLE WORKOUTS
Global Medical Cures™ | AGING- SAMPLE WORKOUTSGlobal Medical Cures™ | AGING- SAMPLE WORKOUTS
Global Medical Cures™ | AGING- SAMPLE WORKOUTSGlobal Medical Cures™
 
Global Medical Cures™ | BIPOLAR DISORDER
Global Medical Cures™ | BIPOLAR DISORDERGlobal Medical Cures™ | BIPOLAR DISORDER
Global Medical Cures™ | BIPOLAR DISORDERGlobal Medical Cures™
 
Global Medical Cures™ | Anger Management for Substance Abuse & Mental Health ...
Global Medical Cures™ | Anger Management for Substance Abuse & Mental Health ...Global Medical Cures™ | Anger Management for Substance Abuse & Mental Health ...
Global Medical Cures™ | Anger Management for Substance Abuse & Mental Health ...Global Medical Cures™
 
Global Medical Cures™ | Help your Child gain control over Asthma
Global Medical Cures™  |  Help your Child gain control over AsthmaGlobal Medical Cures™  |  Help your Child gain control over Asthma
Global Medical Cures™ | Help your Child gain control over AsthmaGlobal Medical Cures™
 
Global Medical Cures™ | Women & Depression
Global Medical Cures™ | Women & DepressionGlobal Medical Cures™ | Women & Depression
Global Medical Cures™ | Women & DepressionGlobal Medical Cures™
 
Global Medical Cures™ | Novel New Drugs- 2013 Summary CDER FDA
Global Medical Cures™ | Novel New Drugs- 2013 Summary CDER FDAGlobal Medical Cures™ | Novel New Drugs- 2013 Summary CDER FDA
Global Medical Cures™ | Novel New Drugs- 2013 Summary CDER FDAGlobal Medical Cures™
 
What's new in System Center 2012 R2: Virtual Machine Manager
What's new in System Center 2012 R2: Virtual Machine ManagerWhat's new in System Center 2012 R2: Virtual Machine Manager
What's new in System Center 2012 R2: Virtual Machine ManagerTomica Kaniski
 
Global Medical Cures™ | Womens health - Sexually Transmitted Infections
Global Medical Cures™ | Womens health - Sexually Transmitted InfectionsGlobal Medical Cures™ | Womens health - Sexually Transmitted Infections
Global Medical Cures™ | Womens health - Sexually Transmitted InfectionsGlobal Medical Cures™
 
Global Medical Cures™ | Responding to America's Prescription Drug Abuse Crisis
Global Medical Cures™ | Responding to America's Prescription Drug Abuse CrisisGlobal Medical Cures™ | Responding to America's Prescription Drug Abuse Crisis
Global Medical Cures™ | Responding to America's Prescription Drug Abuse CrisisGlobal Medical Cures™
 
Global Medical Cures™ | AGE RELATED MACULAR DEGENERATION
Global Medical Cures™ | AGE RELATED MACULAR DEGENERATIONGlobal Medical Cures™ | AGE RELATED MACULAR DEGENERATION
Global Medical Cures™ | AGE RELATED MACULAR DEGENERATIONGlobal Medical Cures™
 
Global Medical Cures™ | Fast Facts- Hip Replacement
Global Medical Cures™ | Fast Facts- Hip ReplacementGlobal Medical Cures™ | Fast Facts- Hip Replacement
Global Medical Cures™ | Fast Facts- Hip ReplacementGlobal Medical Cures™
 

Destaque (15)

Global Medical Cures™ | Womens Health- VIOLENCE AGAINST WOMEN
Global Medical Cures™ | Womens Health- VIOLENCE AGAINST WOMENGlobal Medical Cures™ | Womens Health- VIOLENCE AGAINST WOMEN
Global Medical Cures™ | Womens Health- VIOLENCE AGAINST WOMEN
 
Configuration Manager: zero-touch & Windows 8.1 (MS NetWork 4)
Configuration Manager: zero-touch & Windows 8.1 (MS NetWork 4)Configuration Manager: zero-touch & Windows 8.1 (MS NetWork 4)
Configuration Manager: zero-touch & Windows 8.1 (MS NetWork 4)
 
Global Medical Cures™ | Medicines for Treating Mental Health Conditions
Global Medical Cures™ | Medicines for Treating Mental Health ConditionsGlobal Medical Cures™ | Medicines for Treating Mental Health Conditions
Global Medical Cures™ | Medicines for Treating Mental Health Conditions
 
Global Medical Cures™ | STROKE- Challenges, Progress & Promise
Global Medical Cures™ | STROKE- Challenges, Progress & PromiseGlobal Medical Cures™ | STROKE- Challenges, Progress & Promise
Global Medical Cures™ | STROKE- Challenges, Progress & Promise
 
Global Medical Cures™ | AGING- SAMPLE WORKOUTS
Global Medical Cures™ | AGING- SAMPLE WORKOUTSGlobal Medical Cures™ | AGING- SAMPLE WORKOUTS
Global Medical Cures™ | AGING- SAMPLE WORKOUTS
 
Global Medical Cures™ | BIPOLAR DISORDER
Global Medical Cures™ | BIPOLAR DISORDERGlobal Medical Cures™ | BIPOLAR DISORDER
Global Medical Cures™ | BIPOLAR DISORDER
 
Global Medical Cures™ | Anger Management for Substance Abuse & Mental Health ...
Global Medical Cures™ | Anger Management for Substance Abuse & Mental Health ...Global Medical Cures™ | Anger Management for Substance Abuse & Mental Health ...
Global Medical Cures™ | Anger Management for Substance Abuse & Mental Health ...
 
Global Medical Cures™ | Help your Child gain control over Asthma
Global Medical Cures™  |  Help your Child gain control over AsthmaGlobal Medical Cures™  |  Help your Child gain control over Asthma
Global Medical Cures™ | Help your Child gain control over Asthma
 
Global Medical Cures™ | Women & Depression
Global Medical Cures™ | Women & DepressionGlobal Medical Cures™ | Women & Depression
Global Medical Cures™ | Women & Depression
 
Global Medical Cures™ | Novel New Drugs- 2013 Summary CDER FDA
Global Medical Cures™ | Novel New Drugs- 2013 Summary CDER FDAGlobal Medical Cures™ | Novel New Drugs- 2013 Summary CDER FDA
Global Medical Cures™ | Novel New Drugs- 2013 Summary CDER FDA
 
What's new in System Center 2012 R2: Virtual Machine Manager
What's new in System Center 2012 R2: Virtual Machine ManagerWhat's new in System Center 2012 R2: Virtual Machine Manager
What's new in System Center 2012 R2: Virtual Machine Manager
 
Global Medical Cures™ | Womens health - Sexually Transmitted Infections
Global Medical Cures™ | Womens health - Sexually Transmitted InfectionsGlobal Medical Cures™ | Womens health - Sexually Transmitted Infections
Global Medical Cures™ | Womens health - Sexually Transmitted Infections
 
Global Medical Cures™ | Responding to America's Prescription Drug Abuse Crisis
Global Medical Cures™ | Responding to America's Prescription Drug Abuse CrisisGlobal Medical Cures™ | Responding to America's Prescription Drug Abuse Crisis
Global Medical Cures™ | Responding to America's Prescription Drug Abuse Crisis
 
Global Medical Cures™ | AGE RELATED MACULAR DEGENERATION
Global Medical Cures™ | AGE RELATED MACULAR DEGENERATIONGlobal Medical Cures™ | AGE RELATED MACULAR DEGENERATION
Global Medical Cures™ | AGE RELATED MACULAR DEGENERATION
 
Global Medical Cures™ | Fast Facts- Hip Replacement
Global Medical Cures™ | Fast Facts- Hip ReplacementGlobal Medical Cures™ | Fast Facts- Hip Replacement
Global Medical Cures™ | Fast Facts- Hip Replacement
 

Semelhante a Global Medical Cures™ | NEW YORK STATE- Adult Diabetes Prevalence

Global Medical Cures™ | NEW YORK STATE- Adult Overweight & Obesity Statistics
Global Medical Cures™ | NEW YORK STATE- Adult Overweight & Obesity StatisticsGlobal Medical Cures™ | NEW YORK STATE- Adult Overweight & Obesity Statistics
Global Medical Cures™ | NEW YORK STATE- Adult Overweight & Obesity StatisticsGlobal Medical Cures™
 
Healthy Food Accessibility and Obesity: Case Study of Pennsylvania, USA
Healthy Food Accessibility and Obesity: Case Study of Pennsylvania, USAHealthy Food Accessibility and Obesity: Case Study of Pennsylvania, USA
Healthy Food Accessibility and Obesity: Case Study of Pennsylvania, USArsmahabir
 
Running head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docx
Running head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docxRunning head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docx
Running head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docxjeanettehully
 
Health outcomes of Aboriginal individuals with early onset diabetes
Health outcomes of Aboriginal individuals with early onset diabetesHealth outcomes of Aboriginal individuals with early onset diabetes
Health outcomes of Aboriginal individuals with early onset diabetesKelli Buckreus
 
National health survey - WHO
National health survey - WHONational health survey - WHO
National health survey - WHOamit9099
 
nejm obesidad en adolescente. 2102062.pdf
nejm obesidad en adolescente. 2102062.pdfnejm obesidad en adolescente. 2102062.pdf
nejm obesidad en adolescente. 2102062.pdfmedineumo
 
hp2020_ D_CKD_progress_review_presentation.pptx
hp2020_ D_CKD_progress_review_presentation.pptxhp2020_ D_CKD_progress_review_presentation.pptx
hp2020_ D_CKD_progress_review_presentation.pptxSasha Vaidya
 
Running head Healthy people 2020Healthy people 2020 .docx
Running head Healthy people 2020Healthy people 2020  .docxRunning head Healthy people 2020Healthy people 2020  .docx
Running head Healthy people 2020Healthy people 2020 .docxcowinhelen
 
Diabetes &amp; Texas Medicaid Savings 11 01
Diabetes &amp; Texas Medicaid Savings 11 01Diabetes &amp; Texas Medicaid Savings 11 01
Diabetes &amp; Texas Medicaid Savings 11 01thoenner
 
Hi,follwoing matter and list of reference will useful for your res.pdf
Hi,follwoing matter and list of reference will useful for your res.pdfHi,follwoing matter and list of reference will useful for your res.pdf
Hi,follwoing matter and list of reference will useful for your res.pdfarasequ
 
RunningHead PICOT Question1RunningHead PICOT Question7.docx
RunningHead PICOT Question1RunningHead PICOT Question7.docxRunningHead PICOT Question1RunningHead PICOT Question7.docx
RunningHead PICOT Question1RunningHead PICOT Question7.docxrtodd599
 
Death from liver disease : Implications for end of life care in England
Death from liver disease : Implications for end of life care in EnglandDeath from liver disease : Implications for end of life care in England
Death from liver disease : Implications for end of life care in EnglandNHS IQ legacy organisations
 
Epidemiological studies are applicable to communicable and non-com.docx
Epidemiological studies are applicable to communicable and non-com.docxEpidemiological studies are applicable to communicable and non-com.docx
Epidemiological studies are applicable to communicable and non-com.docxSALU18
 
Henderson Senior Thesis 2010 Final
Henderson Senior Thesis 2010 FinalHenderson Senior Thesis 2010 Final
Henderson Senior Thesis 2010 Finalrobrhenderson
 
Global Medical Cures™ | Kidney Disease Statistics for USA
Global Medical Cures™ | Kidney Disease Statistics for USAGlobal Medical Cures™ | Kidney Disease Statistics for USA
Global Medical Cures™ | Kidney Disease Statistics for USAGlobal Medical Cures™
 
chronic-kidney-disease-elderly.pptx
chronic-kidney-disease-elderly.pptxchronic-kidney-disease-elderly.pptx
chronic-kidney-disease-elderly.pptxHuda693686
 

Semelhante a Global Medical Cures™ | NEW YORK STATE- Adult Diabetes Prevalence (20)

Global Medical Cures™ | NEW YORK STATE- Adult Overweight & Obesity Statistics
Global Medical Cures™ | NEW YORK STATE- Adult Overweight & Obesity StatisticsGlobal Medical Cures™ | NEW YORK STATE- Adult Overweight & Obesity Statistics
Global Medical Cures™ | NEW YORK STATE- Adult Overweight & Obesity Statistics
 
Secretary Rod Bremby Presentation
Secretary Rod  Bremby  PresentationSecretary Rod  Bremby  Presentation
Secretary Rod Bremby Presentation
 
Childhood Obesity
Childhood ObesityChildhood Obesity
Childhood Obesity
 
hus2015.ppt
hus2015.ppthus2015.ppt
hus2015.ppt
 
Healthy Food Accessibility and Obesity: Case Study of Pennsylvania, USA
Healthy Food Accessibility and Obesity: Case Study of Pennsylvania, USAHealthy Food Accessibility and Obesity: Case Study of Pennsylvania, USA
Healthy Food Accessibility and Obesity: Case Study of Pennsylvania, USA
 
Running head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docx
Running head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docxRunning head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docx
Running head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docx
 
Health outcomes of Aboriginal individuals with early onset diabetes
Health outcomes of Aboriginal individuals with early onset diabetesHealth outcomes of Aboriginal individuals with early onset diabetes
Health outcomes of Aboriginal individuals with early onset diabetes
 
National health survey - WHO
National health survey - WHONational health survey - WHO
National health survey - WHO
 
nejm obesidad en adolescente. 2102062.pdf
nejm obesidad en adolescente. 2102062.pdfnejm obesidad en adolescente. 2102062.pdf
nejm obesidad en adolescente. 2102062.pdf
 
poster_diabetes
poster_diabetesposter_diabetes
poster_diabetes
 
hp2020_ D_CKD_progress_review_presentation.pptx
hp2020_ D_CKD_progress_review_presentation.pptxhp2020_ D_CKD_progress_review_presentation.pptx
hp2020_ D_CKD_progress_review_presentation.pptx
 
Running head Healthy people 2020Healthy people 2020 .docx
Running head Healthy people 2020Healthy people 2020  .docxRunning head Healthy people 2020Healthy people 2020  .docx
Running head Healthy people 2020Healthy people 2020 .docx
 
Diabetes &amp; Texas Medicaid Savings 11 01
Diabetes &amp; Texas Medicaid Savings 11 01Diabetes &amp; Texas Medicaid Savings 11 01
Diabetes &amp; Texas Medicaid Savings 11 01
 
Hi,follwoing matter and list of reference will useful for your res.pdf
Hi,follwoing matter and list of reference will useful for your res.pdfHi,follwoing matter and list of reference will useful for your res.pdf
Hi,follwoing matter and list of reference will useful for your res.pdf
 
RunningHead PICOT Question1RunningHead PICOT Question7.docx
RunningHead PICOT Question1RunningHead PICOT Question7.docxRunningHead PICOT Question1RunningHead PICOT Question7.docx
RunningHead PICOT Question1RunningHead PICOT Question7.docx
 
Death from liver disease : Implications for end of life care in England
Death from liver disease : Implications for end of life care in EnglandDeath from liver disease : Implications for end of life care in England
Death from liver disease : Implications for end of life care in England
 
Epidemiological studies are applicable to communicable and non-com.docx
Epidemiological studies are applicable to communicable and non-com.docxEpidemiological studies are applicable to communicable and non-com.docx
Epidemiological studies are applicable to communicable and non-com.docx
 
Henderson Senior Thesis 2010 Final
Henderson Senior Thesis 2010 FinalHenderson Senior Thesis 2010 Final
Henderson Senior Thesis 2010 Final
 
Global Medical Cures™ | Kidney Disease Statistics for USA
Global Medical Cures™ | Kidney Disease Statistics for USAGlobal Medical Cures™ | Kidney Disease Statistics for USA
Global Medical Cures™ | Kidney Disease Statistics for USA
 
chronic-kidney-disease-elderly.pptx
chronic-kidney-disease-elderly.pptxchronic-kidney-disease-elderly.pptx
chronic-kidney-disease-elderly.pptx
 

Mais de Global Medical Cures™

Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia
Lipid Screening in Childhood for Detection of Multifactorial DyslipidemiaLipid Screening in Childhood for Detection of Multifactorial Dyslipidemia
Lipid Screening in Childhood for Detection of Multifactorial DyslipidemiaGlobal Medical Cures™
 
Global Medical Cures™ - Screening for Skin Cancer in Adults
Global Medical Cures™ - Screening for Skin Cancer in AdultsGlobal Medical Cures™ - Screening for Skin Cancer in Adults
Global Medical Cures™ - Screening for Skin Cancer in AdultsGlobal Medical Cures™
 
Global Medical Cures™ | USA Chartbook on HealthCare for Blacks
Global Medical Cures™ | USA Chartbook on HealthCare for BlacksGlobal Medical Cures™ | USA Chartbook on HealthCare for Blacks
Global Medical Cures™ | USA Chartbook on HealthCare for BlacksGlobal Medical Cures™
 
Global Medical Cures™ | Older Americans- Key Indicators of Well Being
Global Medical Cures™ | Older Americans- Key Indicators of Well Being Global Medical Cures™ | Older Americans- Key Indicators of Well Being
Global Medical Cures™ | Older Americans- Key Indicators of Well Being Global Medical Cures™
 
Global Medical Cures™ | Staggering Increase in Generic Drugs Pricing
Global Medical Cures™ | Staggering Increase in Generic Drugs PricingGlobal Medical Cures™ | Staggering Increase in Generic Drugs Pricing
Global Medical Cures™ | Staggering Increase in Generic Drugs PricingGlobal Medical Cures™
 
Global Medical Cures™ | Dangers & Consequences of Marijuana Abuse
Global Medical Cures™ | Dangers & Consequences of Marijuana AbuseGlobal Medical Cures™ | Dangers & Consequences of Marijuana Abuse
Global Medical Cures™ | Dangers & Consequences of Marijuana AbuseGlobal Medical Cures™
 
Global Medical Cures™ | Harmful Interactions
Global Medical Cures™ | Harmful InteractionsGlobal Medical Cures™ | Harmful Interactions
Global Medical Cures™ | Harmful InteractionsGlobal Medical Cures™
 
Global Medical Cures™ | Medicines for Treating Depression
Global Medical Cures™  | Medicines for Treating DepressionGlobal Medical Cures™  | Medicines for Treating Depression
Global Medical Cures™ | Medicines for Treating DepressionGlobal Medical Cures™
 
Global Medical Cures™ | National Strategy for Combating Antibiotic Resistant ...
Global Medical Cures™ | National Strategy for Combating Antibiotic Resistant ...Global Medical Cures™ | National Strategy for Combating Antibiotic Resistant ...
Global Medical Cures™ | National Strategy for Combating Antibiotic Resistant ...Global Medical Cures™
 
Global Medical Cures™ | PCAST Report- Combating Antibiotic Resistance
Global Medical Cures™ | PCAST Report- Combating Antibiotic ResistanceGlobal Medical Cures™ | PCAST Report- Combating Antibiotic Resistance
Global Medical Cures™ | PCAST Report- Combating Antibiotic ResistanceGlobal Medical Cures™
 
Global Medical Cures™ | Physical Activity Guidelines for Americans
Global Medical Cures™ | Physical Activity Guidelines for AmericansGlobal Medical Cures™ | Physical Activity Guidelines for Americans
Global Medical Cures™ | Physical Activity Guidelines for AmericansGlobal Medical Cures™
 
Global Medical Cures™ | Dietary Guidelines for Americans
Global Medical Cures™ | Dietary Guidelines for AmericansGlobal Medical Cures™ | Dietary Guidelines for Americans
Global Medical Cures™ | Dietary Guidelines for AmericansGlobal Medical Cures™
 
Global Medical Cures™ | Aging and your Eyes
Global Medical Cures™ | Aging and your EyesGlobal Medical Cures™ | Aging and your Eyes
Global Medical Cures™ | Aging and your EyesGlobal Medical Cures™
 
Global Medical Cures™ | Drugs approved for Bone Cancer
Global Medical Cures™ | Drugs approved for Bone CancerGlobal Medical Cures™ | Drugs approved for Bone Cancer
Global Medical Cures™ | Drugs approved for Bone CancerGlobal Medical Cures™
 
Global Medical Cures™ | Drugs approved for Breast Cancer
Global Medical Cures™ | Drugs approved for Breast CancerGlobal Medical Cures™ | Drugs approved for Breast Cancer
Global Medical Cures™ | Drugs approved for Breast CancerGlobal Medical Cures™
 
Global Medical Cures™| Drugs approved for Head and Neck Cancer
Global Medical Cures™| Drugs approved for Head and Neck CancerGlobal Medical Cures™| Drugs approved for Head and Neck Cancer
Global Medical Cures™| Drugs approved for Head and Neck CancerGlobal Medical Cures™
 
Global Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma
Global Medical Cures™ | Drugs approved for Non Hodgkin LymphomaGlobal Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma
Global Medical Cures™ | Drugs approved for Non Hodgkin LymphomaGlobal Medical Cures™
 
Global Medical Cures™ |Drugs approved for Pancreatic Cancer
Global Medical Cures™ |Drugs approved for Pancreatic CancerGlobal Medical Cures™ |Drugs approved for Pancreatic Cancer
Global Medical Cures™ |Drugs approved for Pancreatic CancerGlobal Medical Cures™
 
Global Medical Cures™ | Drugs approved for LUNG CANCER
Global Medical Cures™ | Drugs approved for LUNG CANCERGlobal Medical Cures™ | Drugs approved for LUNG CANCER
Global Medical Cures™ | Drugs approved for LUNG CANCERGlobal Medical Cures™
 
Global Medical Cures™ | Treatment of Overactive Bladder in Women- EVIDENCE RE...
Global Medical Cures™ | Treatment of Overactive Bladder in Women- EVIDENCE RE...Global Medical Cures™ | Treatment of Overactive Bladder in Women- EVIDENCE RE...
Global Medical Cures™ | Treatment of Overactive Bladder in Women- EVIDENCE RE...Global Medical Cures™
 

Mais de Global Medical Cures™ (20)

Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia
Lipid Screening in Childhood for Detection of Multifactorial DyslipidemiaLipid Screening in Childhood for Detection of Multifactorial Dyslipidemia
Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia
 
Global Medical Cures™ - Screening for Skin Cancer in Adults
Global Medical Cures™ - Screening for Skin Cancer in AdultsGlobal Medical Cures™ - Screening for Skin Cancer in Adults
Global Medical Cures™ - Screening for Skin Cancer in Adults
 
Global Medical Cures™ | USA Chartbook on HealthCare for Blacks
Global Medical Cures™ | USA Chartbook on HealthCare for BlacksGlobal Medical Cures™ | USA Chartbook on HealthCare for Blacks
Global Medical Cures™ | USA Chartbook on HealthCare for Blacks
 
Global Medical Cures™ | Older Americans- Key Indicators of Well Being
Global Medical Cures™ | Older Americans- Key Indicators of Well Being Global Medical Cures™ | Older Americans- Key Indicators of Well Being
Global Medical Cures™ | Older Americans- Key Indicators of Well Being
 
Global Medical Cures™ | Staggering Increase in Generic Drugs Pricing
Global Medical Cures™ | Staggering Increase in Generic Drugs PricingGlobal Medical Cures™ | Staggering Increase in Generic Drugs Pricing
Global Medical Cures™ | Staggering Increase in Generic Drugs Pricing
 
Global Medical Cures™ | Dangers & Consequences of Marijuana Abuse
Global Medical Cures™ | Dangers & Consequences of Marijuana AbuseGlobal Medical Cures™ | Dangers & Consequences of Marijuana Abuse
Global Medical Cures™ | Dangers & Consequences of Marijuana Abuse
 
Global Medical Cures™ | Harmful Interactions
Global Medical Cures™ | Harmful InteractionsGlobal Medical Cures™ | Harmful Interactions
Global Medical Cures™ | Harmful Interactions
 
Global Medical Cures™ | Medicines for Treating Depression
Global Medical Cures™  | Medicines for Treating DepressionGlobal Medical Cures™  | Medicines for Treating Depression
Global Medical Cures™ | Medicines for Treating Depression
 
Global Medical Cures™ | National Strategy for Combating Antibiotic Resistant ...
Global Medical Cures™ | National Strategy for Combating Antibiotic Resistant ...Global Medical Cures™ | National Strategy for Combating Antibiotic Resistant ...
Global Medical Cures™ | National Strategy for Combating Antibiotic Resistant ...
 
Global Medical Cures™ | PCAST Report- Combating Antibiotic Resistance
Global Medical Cures™ | PCAST Report- Combating Antibiotic ResistanceGlobal Medical Cures™ | PCAST Report- Combating Antibiotic Resistance
Global Medical Cures™ | PCAST Report- Combating Antibiotic Resistance
 
Global Medical Cures™ | Physical Activity Guidelines for Americans
Global Medical Cures™ | Physical Activity Guidelines for AmericansGlobal Medical Cures™ | Physical Activity Guidelines for Americans
Global Medical Cures™ | Physical Activity Guidelines for Americans
 
Global Medical Cures™ | Dietary Guidelines for Americans
Global Medical Cures™ | Dietary Guidelines for AmericansGlobal Medical Cures™ | Dietary Guidelines for Americans
Global Medical Cures™ | Dietary Guidelines for Americans
 
Global Medical Cures™ | Aging and your Eyes
Global Medical Cures™ | Aging and your EyesGlobal Medical Cures™ | Aging and your Eyes
Global Medical Cures™ | Aging and your Eyes
 
Global Medical Cures™ | Drugs approved for Bone Cancer
Global Medical Cures™ | Drugs approved for Bone CancerGlobal Medical Cures™ | Drugs approved for Bone Cancer
Global Medical Cures™ | Drugs approved for Bone Cancer
 
Global Medical Cures™ | Drugs approved for Breast Cancer
Global Medical Cures™ | Drugs approved for Breast CancerGlobal Medical Cures™ | Drugs approved for Breast Cancer
Global Medical Cures™ | Drugs approved for Breast Cancer
 
Global Medical Cures™| Drugs approved for Head and Neck Cancer
Global Medical Cures™| Drugs approved for Head and Neck CancerGlobal Medical Cures™| Drugs approved for Head and Neck Cancer
Global Medical Cures™| Drugs approved for Head and Neck Cancer
 
Global Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma
Global Medical Cures™ | Drugs approved for Non Hodgkin LymphomaGlobal Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma
Global Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma
 
Global Medical Cures™ |Drugs approved for Pancreatic Cancer
Global Medical Cures™ |Drugs approved for Pancreatic CancerGlobal Medical Cures™ |Drugs approved for Pancreatic Cancer
Global Medical Cures™ |Drugs approved for Pancreatic Cancer
 
Global Medical Cures™ | Drugs approved for LUNG CANCER
Global Medical Cures™ | Drugs approved for LUNG CANCERGlobal Medical Cures™ | Drugs approved for LUNG CANCER
Global Medical Cures™ | Drugs approved for LUNG CANCER
 
Global Medical Cures™ | Treatment of Overactive Bladder in Women- EVIDENCE RE...
Global Medical Cures™ | Treatment of Overactive Bladder in Women- EVIDENCE RE...Global Medical Cures™ | Treatment of Overactive Bladder in Women- EVIDENCE RE...
Global Medical Cures™ | Treatment of Overactive Bladder in Women- EVIDENCE RE...
 

Último

Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabad
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In FaridabadCall Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabad
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabadgragmanisha42
 
Vip Kolkata Call Girls Cossipore 👉 8250192130 ❣️💯 Available With Room 24×7
Vip Kolkata Call Girls Cossipore 👉 8250192130 ❣️💯 Available With Room 24×7Vip Kolkata Call Girls Cossipore 👉 8250192130 ❣️💯 Available With Room 24×7
Vip Kolkata Call Girls Cossipore 👉 8250192130 ❣️💯 Available With Room 24×7Miss joya
 
Jalandhar Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
Jalandhar  Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...Jalandhar  Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
Jalandhar Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...Call Girls Service Chandigarh Ayushi
 
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near MeVIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Memriyagarg453
 
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR Call G...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR   Call G...❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR   Call G...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR Call G...Gfnyt.com
 
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591adityaroy0215
 
Ozhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ozhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetOzhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ozhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Service
 
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋Sheetaleventcompany
 
Call Girls In ludhiana For Fun 9053900678 By ludhiana Call Girls For Pick...
Call Girls In  ludhiana  For Fun 9053900678 By  ludhiana  Call Girls For Pick...Call Girls In  ludhiana  For Fun 9053900678 By  ludhiana  Call Girls For Pick...
Call Girls In ludhiana For Fun 9053900678 By ludhiana Call Girls For Pick...Russian Call Girls in Ludhiana
 
Russian Call Girls Lucknow ₹7.5k Pick Up & Drop With Cash Payment 8923113531 ...
Russian Call Girls Lucknow ₹7.5k Pick Up & Drop With Cash Payment 8923113531 ...Russian Call Girls Lucknow ₹7.5k Pick Up & Drop With Cash Payment 8923113531 ...
Russian Call Girls Lucknow ₹7.5k Pick Up & Drop With Cash Payment 8923113531 ...gurkirankumar98700
 
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Dehradun Call Girls Service 08854095900 Real Russian Girls Looking Models
Dehradun Call Girls Service 08854095900 Real Russian Girls Looking ModelsDehradun Call Girls Service 08854095900 Real Russian Girls Looking Models
Dehradun Call Girls Service 08854095900 Real Russian Girls Looking Modelsindiancallgirl4rent
 
Call Girls Amritsar 💯Call Us 🔝 8725944379 🔝 💃 Independent Escort Service Amri...
Call Girls Amritsar 💯Call Us 🔝 8725944379 🔝 💃 Independent Escort Service Amri...Call Girls Amritsar 💯Call Us 🔝 8725944379 🔝 💃 Independent Escort Service Amri...
Call Girls Amritsar 💯Call Us 🔝 8725944379 🔝 💃 Independent Escort Service Amri...Niamh verma
 
Krishnagiri call girls Tamil aunty 7877702510
Krishnagiri call girls Tamil aunty 7877702510Krishnagiri call girls Tamil aunty 7877702510
Krishnagiri call girls Tamil aunty 7877702510Vipesco
 
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknow
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in LucknowRussian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknow
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknowgragteena
 
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Bangalore call girl 👯‍♀️@ Simran Independent Call Girls in Bangalore GIUXUZ...
Bangalore call girl  👯‍♀️@ Simran Independent Call Girls in Bangalore  GIUXUZ...Bangalore call girl  👯‍♀️@ Simran Independent Call Girls in Bangalore  GIUXUZ...
Bangalore call girl 👯‍♀️@ Simran Independent Call Girls in Bangalore GIUXUZ...Gfnyt
 
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real MeetCall Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meetpriyashah722354
 
💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋Sheetaleventcompany
 
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipur
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In RaipurCall Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipur
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipurgragmanisha42
 

Último (20)

Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabad
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In FaridabadCall Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabad
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabad
 
Vip Kolkata Call Girls Cossipore 👉 8250192130 ❣️💯 Available With Room 24×7
Vip Kolkata Call Girls Cossipore 👉 8250192130 ❣️💯 Available With Room 24×7Vip Kolkata Call Girls Cossipore 👉 8250192130 ❣️💯 Available With Room 24×7
Vip Kolkata Call Girls Cossipore 👉 8250192130 ❣️💯 Available With Room 24×7
 
Jalandhar Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
Jalandhar  Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...Jalandhar  Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
Jalandhar Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
 
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near MeVIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
 
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR Call G...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR   Call G...❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR   Call G...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR Call G...
 
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591
 
Ozhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ozhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetOzhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ozhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
 
Call Girls In ludhiana For Fun 9053900678 By ludhiana Call Girls For Pick...
Call Girls In  ludhiana  For Fun 9053900678 By  ludhiana  Call Girls For Pick...Call Girls In  ludhiana  For Fun 9053900678 By  ludhiana  Call Girls For Pick...
Call Girls In ludhiana For Fun 9053900678 By ludhiana Call Girls For Pick...
 
Russian Call Girls Lucknow ₹7.5k Pick Up & Drop With Cash Payment 8923113531 ...
Russian Call Girls Lucknow ₹7.5k Pick Up & Drop With Cash Payment 8923113531 ...Russian Call Girls Lucknow ₹7.5k Pick Up & Drop With Cash Payment 8923113531 ...
Russian Call Girls Lucknow ₹7.5k Pick Up & Drop With Cash Payment 8923113531 ...
 
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 9907093804 Top Class Call Girl Service Available
 
Dehradun Call Girls Service 08854095900 Real Russian Girls Looking Models
Dehradun Call Girls Service 08854095900 Real Russian Girls Looking ModelsDehradun Call Girls Service 08854095900 Real Russian Girls Looking Models
Dehradun Call Girls Service 08854095900 Real Russian Girls Looking Models
 
Call Girls Amritsar 💯Call Us 🔝 8725944379 🔝 💃 Independent Escort Service Amri...
Call Girls Amritsar 💯Call Us 🔝 8725944379 🔝 💃 Independent Escort Service Amri...Call Girls Amritsar 💯Call Us 🔝 8725944379 🔝 💃 Independent Escort Service Amri...
Call Girls Amritsar 💯Call Us 🔝 8725944379 🔝 💃 Independent Escort Service Amri...
 
Krishnagiri call girls Tamil aunty 7877702510
Krishnagiri call girls Tamil aunty 7877702510Krishnagiri call girls Tamil aunty 7877702510
Krishnagiri call girls Tamil aunty 7877702510
 
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknow
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in LucknowRussian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknow
Russian Escorts Aishbagh Road * 9548273370 Naughty Call Girls Service in Lucknow
 
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
 
Bangalore call girl 👯‍♀️@ Simran Independent Call Girls in Bangalore GIUXUZ...
Bangalore call girl  👯‍♀️@ Simran Independent Call Girls in Bangalore  GIUXUZ...Bangalore call girl  👯‍♀️@ Simran Independent Call Girls in Bangalore  GIUXUZ...
Bangalore call girl 👯‍♀️@ Simran Independent Call Girls in Bangalore GIUXUZ...
 
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real MeetCall Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
 
💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋
 
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipur
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In RaipurCall Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipur
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipur
 

Global Medical Cures™ | NEW YORK STATE- Adult Diabetes Prevalence

  • 1. Prevalence Diabetes in New York State Adult Diabetes Prevention and Control Program Bureau of Chronic Disease Evaluation and Research New York State Department of Health
  • 2. ii Authors: Bureau of Chronic Disease Evaluation and Research Rachael Ruberto, MPH, CPH, CHES Ian Brissette, PhD Bureau of Community Chronic Disease Prevention Maureen Spence, MS, RD, CDN Tracy Mills, MPP For additional information about this report: Rachael Ruberto, MPH, CPH, CHES Bureau of Chronic Disease Evaluation and Research Division of Chronic Disease Prevention New York State Department of Health Empire State Plaza Corning Tower, Room 565 Albany, NY 12237 518-474-2434 rxr24@health.state.ny.us For additional information about the Diabetes Prevention and Control Program: Maureen Spence, MS, RD, CDN Director, Diabetes Prevention and Control Program Bureau of Community Chronic Disease Prevention Division of Chronic Disease Prevention New York State Department of Health Riverview Center 150 Broadway, 3rd Floor West Albany, NY 12204 518-408-0125 mms07@health.state.ny.us This report was supported by Cooperative Agreement Number 1U58/DP00-1963-03 from the National Center for Chronic Disease Prevention and Health Promotion, United States Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the CDC.
  • 3. iii Table of Contents Executive Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iv List of Figures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v List of Tables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vi Diabetes Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 Surveillance Indicators and Data Sources . . . . . . . . . . . . . . . . . . . . . . . . 3 Data Standards and Objectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Diagnosed Diabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 Undiagnosed Diabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 Prediabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 Gestational Diabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
  • 4. iv Executive Summary Adult Diabetes Prevalence in New York State examines data on the prevalence of diagnosed and undiagnosed diabetes, prediabetes, and gestational diabetes among New York State (NYS) adults. Using the NYS Behavioral Risk Factor Surveillance System (BRFSS), NYS Vital Statistics, and the Centers for Disease Control and Prevention’s Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) as data sources, the report summarizes information about the prevalence of diabetes by year and selected demographic characteristics, including age, gender, race/ethnicity, household income, educational attainment, and region. This Executive Summary offers highlights of the diabetes-related information in New York State detailed throughout the report. • The prevalence of self-reported diabetes among adults in NYS has increased steadily over the past 11 years. The three-year moving average has nearly doubled from 4.6% in 1996-1998 to 8.5% in 2007-2009. • The risk of diabetes increases with age. • Diabetes is most prevalent among adults between the ages of 65-74 years (20.3%). • Self-reported diabetes is more prevalent among non-Hispanic blacks (12.1%) than among non-Hispanic whites (7.7%). • Although the majority of adults with diabetes living in NYS are non-Hispanic whites, racial/ ethnic minorities make up a larger proportion of the population of adults with diabetes (44%) than the total NYS population (32%). • Adults with an annual household income less than $15,000 are nearly three times as likely to report having diabetes as adults with an annual household income of more than $50,000 (15.2% versus 5.2%). • Approximately two-thirds of adults living with diabetes (66%) reside outside of New York City. • National estimates from 2005-2006 indicate that 5.1% of adults above the age of 20 had undiagnosed diabetes.1 These estimates can be applied to give a general estimate of the prevalence of undiagnosed diabetes in the NYS population (760,000 adults above the age of 20). • Testing for high blood sugar is less prevalent among adults without health insurance compared to adults who report having health insurance (42% versus 62%) and among adults without a regular healthcare provider compared to adults with a regular healthcare provider (38% versus 64%). • Prediabetes is more prevalent among adults who are obese (10.7%) or overweight (5.3%) than among adults who are neither overweight nor obese (2.9%). • The prevalence of gestational diabetes in NYS has steadily increased from 1995 (35.5 per 1,000 live births) to 2006 (47.3 per 1,000 live births). In NYS, the prevalence of gestational diabetes is highest among Asian women (7.9%).
  • 5. v List of Figures Figure 1. Prevalence of diabetes among New York State (NYS) adults, BRFSS 1996-2009 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 Figure 2. Prevalence of diabetes among New York State (NYS) adults by age, BRFSS 2007-2009 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 Figure 3. Age distribution of New York State (NYS) adults with diabetes, BRFSS 2007-2009 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .10 Figure 4. Prevalence of diabetes among New York State (NYS) adults by gender, BRFSS 2007-2009 . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Figure 5. Prevalence of diabetes among New York State (NYS) adults by age and gender, BRFSS 2007-2009 . . . . . . . . . . . . . . . . . . . . . .12 Figure 6. Prevalence of diabetes among New York State (NYS) adults by race/ethnicity, BRFSS 2007-2009 . . . . . . . . . . . . . . . . . . . . . . . 13 Figure 7. Race/ethnicity of New York State (NYS) adults with diabetes, BRFSS 2007-2009 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .14 Figure 8. Prevalence of diabetes among New York State (NYS) adults by annual household income level, BRFSS 2007-2009 . . . . . . . . . . . .15 Figure 9. Prevalence of diabetes among New York State (NYS) adults by education level, BRFSS 2007-2009 . . . . . . . . . . . . . . . . . . . . . .16 Figure 10. Prevalence of diabetes among New York State (NYS) adults by region, BRFSS 2007-2009 . . . . . . . . . . . . . . . . . . . . . . . . . . . .17 Figure 11. Regional distribution of New York State (NYS) adults with diabetes, BRFSS 2007-2009 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .18 Figure 12. Percentage of adults in New York State (NYS) receiving a test for high blood sugar or diabetes in the past three years by age, BRFSS 2008-2009 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21 Figure 13. Percentage of adults in New York State (NYS) receiving a test for high blood sugar or diabetes in the past three years by access to care indicators, BRFSS 2008-2009 . . . . . . . . . . . . . . . 22 Figure 14. Prevalence of prediabetes among New York State (NYS) adults by age, BRFSS 2008-2009 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 Figure 15. Prevalence of prediabetes among New York State (NYS) adults by race/ethnicity, BRFSS 2008-2009 . . . . . . . . . . . . . . . . . . . . . . 25 Figure 16. Prevalence of prediabetes among New York State (NYS) adults by Body Mass Index (BMI) category, BRFSS 2008-2009 . . . . . . . . . . 26 Figure 17. Prevalence of gestational diabetes in the United States (US) and New York State (NYS), CDC WONDER 1995-2006 . . . . . . . . . . . 28 Figure 18. Prevalence of gestational diabetes in New York State (NYS) by race/ethnicity of mother, NYSDOH Biometrics, 2007 . . . . . . . . . . 29
  • 6. vi List of Tables Table 1. Prevalence of diabetes among New York State (NYS) adults, BRFSS 1996-2009 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Table 2. Percentage of adults in New York State (NYS) receiving a test for high blood sugar or diabetes in the past three years by selected demographic characteristics, BRFSS 2008-2009 . . . . . . . 20
  • 7. 1 Diabetes Overview Diabetes is a disease in which blood sugar (glucose) levels are above normal.2 Glucose, a form of sugar created from digestion of food, is used by the body for energy with the help of a hormone known as insulin. In people with diabetes, glucose cannot easily be used by the cells of the body because of a problem with insulin. This leads to high levels of glucose in the blood, sometimes referred to as high blood sugar or hyperglycemia. Types of Diabetes The difference between various types of diabetes is based mostly on the specific problem occurring with the hormone, insulin. Insulin is made by and released from the pancreas, an organ that sits behind the stomach. In some types of diabetes, the cells that make insulin are damaged, which leads to an inability to produce insulin. In other types of diabetes, insulin is produced by the pancreas, but other tissues of the body do not recognize it. Both types lead to high blood glucose. The following table highlights the most common types of diabetes:3,4 Type Description Type 1 Diabetes • Cells in the pancreas are damaged leading to a decreased release of insulin. • Cell damage usually leads to a total lack of insulin production. Type 2 Diabetes • Insulin is not used properly by the body, so glucose is not absorbed. • There may be a problem with insulin being secreted by the pancreas. Gestational Diabetes • Diabetes develops during pregnancy. • Diabetes often resolves after delivery, although these women are at increased risk for development of type 2 diabetes in the future. Prediabetes • The blood glucose level is high, but not high enough to meet the criteria for diabetes. • Prediabetes is a risk factor for future diabetes.
  • 8. 2 Diagnosing and Classifying Diabetes and Prediabetes Diabetes can be diagnosed in any one of four ways.5, 6 1. Hemoglobin A1C test (A1C) a non-fasting blood test that measures the amount of glucose attached to hemoglobin. This test is used to assess blood glucose control over the previous 2-3 months, and has recently been added to the list of tests that may be used to diagnose diabetes. 2. Fasting plasma glucose test (FPG) a blood test that measures glucose after a person has not eaten for at least 8 hours. 3. Oral glucose tolerance test (OGTT) a blood test that measures glucose after a person has not eaten for 8 hours and 2 hours after that person has consumed a glucose-containing drink. 4. Random plasma glucose test (RPG) a blood test that measures glucose which doesn’t require a person to fast prior to the test. RPG is only used as a diagnostic criterion for diabetes when the patient has classic symptoms of hyperglycemia or hyperglycemic crisis. The results of any of the above tests can be used to determine whether diabetes or prediabetes is present. Positive tests should be repeated on a different day to be sure the above results are correct. DIABETES ≥ 6.5% < 6.4% ≥ 5.7% < 5.7% PRE-DIABETES NORMAL DIABETES ≥ 126 mg/dl < 126 mg/dl ≥ 100 mg/dl < 100 mg/dl PRE-DIABETES NORMAL DIABETES ≥ 200 mg/dl < 200 mg/dl ≥ 140 mg/dl < 140 mg/dl PRE-DIABETES NORMAL A1C FPG OGTT
  • 9. 3 Surveillance Indicators and Data Sources Diagnosed diabetes The Behavioral Risk Factor Surveillance System (BRFSS) is used to assess and track the prevalence of diabetes in adults. The BRFSS is a statewide random-digit-dialing telephone survey of the non- institutionalized adult population aged 18 years and older. The annual NYS BRFSS survey includes a question assessing whether the survey respondent had been diagnosed with diabetes (Have you ever been told by a doctor that you have diabetes?) and a follow-up question to exclude women who may have had gestational diabetes (Was this only when you were pregnant?). Data obtained from these questions can be used to estimate the prevalence of diagnosed diabetes in the adult population. The questions cannot distinguish between adults with Type I and Type II diabetes. More information about the BRFSS survey method is available on the BRFSS page on the New York State Department of Health (NYSDOH) website. http://www.nyhealth.gov/nysdoh/brfss/ Three successive years of BRFSS data were combined to calculate the weighted estimates of the prevalence of diagnosed diabetes in NYS. These prevalence estimates are more stable than those based on a single year of data and provide an adequate sample for subgroup comparisons. The 95% confidence intervals (CIs) for these estimates are provided in data tables reported, but are not included in the figures. Undiagnosed diabetes To conduct public health surveillance on undiagnosed diabetes in New York State would require routinely conducting a state specific survey in which the determination of whether an individual has diabetes is based on appropriate clinical diagnostic tests and not self-report. There is currently no data source in New York State for conducting surveillance on undiagnosed diabetes. However, the NYS BRFSS provides information on the proportion of adults who receive the appropriate diagnostic test for diabetes. In 2008 and 2009, the NYS BRFSS survey included a question for assessing screening for diabetes in the past three years (Have you had a test for high blood sugar or diabetes within the past three years?) Two successive years of BRFSS data were combined to calculate the weighted estimates of the prevalence of testing for high blood sugar or diabetes within the past three years. Prediabetes The NYS BRFSS is also used to assess and track the prevalence of diagnosed prediabetes in adults. In 2008 and 2009, the BRFSS survey included questions for assessing screening for diabetes in the past three years (Have you had a test for high blood sugar or diabetes within the past three years?) and physician diagnosis of prediabetes (Have you ever been told by a doctor or other health professional that you have prediabetes or borderline diabetes?). Data from these two questions in the 2008 and 2009 BRFSS were combined to calculate the weighted estimates of the prevalence of self-reported prediabetes. Gestational diabetes Data from several sources were used to document the gestational diabetes (GDM) prevalence. Public- use natality (live birth) data maintained through the National Center for Health Statistics (NCHS) were obtained via the CDC WONDER online database and used to compare changes in rates of gestational diabetes in the US and New York State. The dataset includes counts of births occurring within the United States to US residents and non-residents between 1995 and 2006. State and county are defined by the mother’s place of residence recorded on the birth certificate. Data elements include demographics, medical risk factors and maternal tobacco use.7 Rates of gestational diabetes for New York State and the US are calculated as the number of singleton births to women where maternal
  • 10. 4 diabetes was reported as a risk factor on the birth certificate. All rates are expressed per 1,000 live births. Vital statistics data from the New York State Bureau of Biometrics and Health Statistics were used to examine differences in the prevalence of GDM in New York State by race/ethnicity. The prevalence of gestational diabetes was calculated for each category of maternal race as the number of live births to women with gestational diabetes divided by the total births in New York State for 2007. For more information on any of the gestational diabetes data sources detailed above, please visit the following links: http://wonder.cdc.gov/natality.html http://www.nyhealth.gov/nysdoh/vital_statistics/
  • 11. 5 Data Standards and Objectives NYS Department of Health Prevention Agenda Toward the Healthiest State In 2008, the New York State Department of Health (NYSDOH) launched a Prevention Agenda Toward the Healthiest State to support the goals of health care reform. This agenda established ten statewide public health priorities and called upon local health departments, hospitals and other community partners to work together to address them. The emphasis of this public health initiative is on prevention strategies to improve the health of all New Yorkers and foster healthy communities. The Prevention Agenda established a goal of reducing the prevalence of diagnosed diabetes, as assessed using the BRFSS, to 5.7% by 2013. More information about the NYSDOH Prevention Agenda is available on the Prevention Agenda page on the NYSDOH website. http://nyhealth.gov/prevention/prevention_agenda/index.htm Healthy People 2020 Healthy People 2020 (HP2020) are a comprehensive set of disease prevention and health promotion objectives for the Nation to achieve over the next ten years. HP2020 established objectives aimed at reducing the economic burden of diabetes, and improving the quality of life for all persons who have or are at risk for diabetes. These objectives include a target related to increasing the proportion of adults aged 20 and older with diabetes whose condition has been diagnosed (objective #D-15), as assessed using the National Health and Nutrition Examination Survey (NHANES), from 72.8% in 2005- 2008 to 80.1% in 2020. Although there is not a NYS-specific data set for tracking the HP2020 objective, data from the NYS BRFSS on the percentage of adults receiving a blood glucose test for diabetes can serve to assess progress toward reducing undiagnosed diabetes in NYS. For more information about HP2020, please use the following link: http://www.healthypeople.gov/2020/default.aspx
  • 12. 6
  • 13. 5 10 15 New York State New York State Prevention Agenda 2013 Target 0 1997-1999 1999-2001 2001-2003 2003-2005 2005-2007 2007-2009 5.7 7 Diagnosed Diabetes Figure 1. Prevalence of diabetes among New York State (NYS) adults, BRFSS 1996-2009 The prevalence of self-reported diabetes among adults in NYS has increased steadily over the past 11 years. The three-year moving average has nearly doubled from 4.6% in 1996-1998 to 8.5% in 2007-2009. The Centers for Disease Control and Prevention indicate that 8.3% of adults in the US report being diagnosed with diabetes (US BRFSS, 2006-2008). This is comparable to the 8.5% estimated in NYS. The current self-reported prevalence of diabetes in NYS (8.5%) is well above the objective identified in the Prevention Agenda (5.7%). For more information on the NYSDOH Prevention Agenda Toward the Healthiest State, please visit: http://www.nyhealth.gov/ prevention/prevention_agenda/
  • 14. 8 Table 1. Prevalence of diabetes among New York State (NYS) adults, BRFSS 1996-2009 Year Percent Lower 95% CI† Upper 95% CI† Prevention Agenda Target* 5.7% - - 1996-1998** 4.6 4.1 5.1 1997-1999 5.4 4.9 6.0 1998-2000 6.0 5.4 6.6 1999-2001 6.3 5.7 6.8 2000-2002 6.8 6.2 7.3 2001-2003 7.1 6.6 7.7 2002-2004 7.4 6.9 7.9 2003-2005 7.7 7.3 8.2 2004-2006 7.8 7.3 8.3 2005-2007 8.0 7.5 8.4 2006-2008 8.1 7.7 8.5 2007-2009 8.5 8.0 8.9 *The Prevention Agenda Target of 5.7% was established in 2008. **In 1997, the diagnostic criteria recommended for diagnosing diabetes changed to include a lower cut-point for fasting plasma glucose values used to classify someone as having Type 2 diabetes. †CI = confidence interval.
  • 15. 2.2 12.0 20.3 19.0 0 5 10 15 20 25 18 - 44 yrs 45 - 64 yrs 65 - 74 yrs 75 yrs or older Percent 9 Figure 2. Prevalence of diabetes among New York State (NYS) adults by age, BRFSS 2007-2009 Age Group Percent Lower 95% CI Upper 95% CI 18-44 yrs 2.2 1.7 2.6 45-64 yrs 12.0 11.1 12.9 65-74 yrs 20.3 18.6 22.1 75 yrs or older 19.0 17.2 20.8 The risk of diabetes increases with age. The prevalence of diabetes is highest among adults between the ages of 65-74 years (20.3%). Diabetes is over 5 times more prevalent among adults between the ages of 45 and 64 years (12.0%) than among adults aged 18 to 44 years (2.2%).
  • 16. 18 - 44 years 45 - 64 years 65 - 74 years 75 years or older 12.5% 18.2% 22.6% 46.7% 10 Figure 3. Age distribution of New York State (NYS) adults with diabetes, BRFSS 2007-2009 Age Group Percent Lower 95% CI Upper 95% CI 18-44 yrs 12.5 10.2 14.8 45-64 yrs 46.7 44.0 49.4 65-74 yrs 22.6 20.6 24.6 75 yrs or older 18.2 16.4 20.0 Adults between the ages of 45 and 64 years represent almost one-half (46.7%) of the adults living with diabetes in NYS.
  • 17. Male Female 8.1 8.9 0 2 4 6 8 10 Percent 11 Figure 4. Prevalence of diabetes among New York State (NYS) adults by gender, BRFSS 2007-2009 Gender Percent Lower 95% CI Upper 95% CI Male 8.9 8.2 9.6 Female 8.1 7.5 8.7 The prevalence of diabetes in NYS does not differ statistically among males and females.
  • 18. Male Female 18-44 yrs 45-64 yrs 65-74 yrs 75 yrs or older 17.718.3 10.6 2.2 21.2 22.8 13.5 2.1 0 5 10 15 20 25 Percent 12 Figure 5. Prevalence of diabetes among New York State (NYS) adults by age and gender, BRFSS 2007-2009 Gender Percent Lower 95% CI Upper 95% CI Male 18-44 yrs 2.1 1.5 2.7 45-64 yrs 13.5 12.0 15.0 65-74 yrs 22.8 20.0 25.7 75 yrs or older 21.2 18.1 24.3 Female 18-44 yrs 2.2 1.6 2.8 45-64 yrs 10.6 9.5 11.7 65-74 yrs 18.3 16.2 20.4 75 yrs or older 17.7 15.5 19.8 Diabetes prevalence increases with age among both men and women.
  • 19. Non-Hispanic white Non-Hispanic black Hispanic Non-Hispanic Asian 5.7 8.3 12.1 7.7 0 5 10 15 Percent 13 Figure 6. Prevalence of diabetes among New York State (NYS) adults by race/ethnicity, BRFSS 2007-2009 Race/Ethnicity Percent Lower 95% CI Upper 95% CI Non-Hispanic white 7.7 7.3 8.2 Non-Hispanic black 12.1 10.5 13.8 Hispanic 8.3 6.9 9.8 Non-Hispanic Asian 5.7 3.6 7.9 Self-reported diabetes is more prevalent among non-Hispanic blacks (12.1%) than among non-Hispanic whites (7.7%).
  • 20. Non-Hispanic white Non-Hispanic black Hispanic Non-Hispanic Asian Non-Hispanic other 5.8% 3.4% 15.6% 19.8% 55.3% 14 Figure 7. Race/ethnicity of New York State (NYS) adults with diabetes, BRFSS 2007-2009 Race/Ethnicity Percent Lower 95% CI Upper 95% CI Non-Hispanic white 55.3 52.5 58.2 Non-Hispanic black 19.8 17.4 22.2 Hispanic 15.6 13.2 18.1 Non-Hispanic Asian 3.4 2.1 4.7 Non-Hispanic other 5.8 4.3 7.3 Although the majority of adults with diabetes living in NYS are non-Hispanic whites (55%), racial/ethnic minorities make up a larger proportion of the population of adults with diabetes (45%) than the total population (32%).
  • 21. <$15,000 15.2 $15-24,999 12.5 $25-34,999 9.9 $35-49,999 9.3 $50,000 or more 5.2 0 5 10 20 Percent 15 15 Figure 8. Prevalence of diabetes among New York State (NYS) adults by annual household income level, BRFSS 2007-2009 Annual Income Percent Lower 95% CI Upper 95% CI <$15,000 15.2 13.2 17.3 $15-24,999 12.5 11.0 14.0 $25-34,999 9.9 8.3 11.6 $35-49,999 9.3 7.9 10.7 $50,000 or more 5.2 4.7 5.8 Adults with an annual household income of less than $15,000 are almost three times as likely to report having diabetes as adults with an annual household income of more than $50,000 (15.2% versus 5.2%).
  • 22. 16 Figure 9. Prevalence of diabetes among New York State (NYS) adults by education level, BRFSS 2007-2009 Education Percent Lower 95% CI Upper 95% CI <High school 13.0 11.1 15.0 High school or general equivalency diploma 11.0 10.0 12.0 Some post high school 8.5 7.7 9.4 College graduate 5.4 4.8 5.9 Adults with less than a high school education are more than twice as likely to report having diabetes as adults who are college graduates (13.0% versus 5.4%). The prevalence of diabetes becomes increasingly greater among segments of the population that are lower in educational attainment and household income. <High school 13.0 High school or General Equivalency Diploma (GED) 11.0 Some post high school 8.5 College graduate 5.4 0 5 10 15 Percent
  • 23. New York State (excluding NYC) 8.4 New York City 8.7 0 2 4 6 8 10 Percent 17 Figure 10. Prevalence of diabetes among New York State (NYS) adults by region, BRFSS 2007-2009 Region Percent Lower 95% CI Upper 95% CI New York City 8.7 7.8 9.6 New York State (excluding New York City) 8.4 7.9 8.9 The prevalence of diabetes among adults residing in New York State (excluding New York City) does not differ statistically from the prevalence of diabetes among adults in New York City. County level data on the prevalence of diabetes in NYS can be found at the website: http://www.nyhealth.gov/statistics/brfss/expanded/ Data on the prevalence of diabetes collected through the New York City Department of Health and Mental Hygiene can be obtained at the website: http://www.nyc.gov/html/doh/ downloads/pdf/epi/diabetes_chart_book.pdf
  • 24. New York City New York State (excluding New York City) 65.6% 34.4% 18 Figure 11. Regional distribution of New York State (NYS) adults with diabetes, BRFSS 2007-2009 Region Percent Lower 95% CI Upper 95% CI New York City 34.4 31.7 37.2 New York State (excluding New York City) 65.6 62.8 68.3 Approximately two-thirds of NYS adults living with diabetes (66%) reside outside of New York City.
  • 25. 19 Undiagnosed Diabetes The prevalence of adult diabetes in the New York State population includes instances where diabetes is diagnosed by a medical care professional and instances where it has not yet been detected. The previous section of the report summarized data on the percentage of adults with diagnosed diabetes. This represents only a portion of adults living with this chronic disease. Diabetes can go undetected among those who do not receive medical care or do not receive the appropriate diagnostic tests from their medical care providers. In New York State there is no system for conducting public health surveillance on undiagnosed diabetes. Data from the National Health and Nutrition Examination Survey (NHANES), a survey designed to enroll a representative sample of the US civilian population, estimate that in 2005-2006, 5.1% of adults above the age of 20 had undiagnosed diabetes.8 These national estimates can be applied to give a general estimate of the prevalence of undiagnosed diabetes in the New York State population (760,000 adults). However, this estimate does not take into consideration how the population of New York adults differs from adults in the rest of the US population or how rates of diagnostic testing for diabetes differ in New York as compared to other States. For more information about the NHANES, please use the following link: http://www.cdc.gov/nchs/nhanes.htm Reducing undiagnosed diabetes is a priority in diabetes prevention and control. Healthy People 2020 includes an objective to increase the percentage of adults with diabetes whose condition has been diagnosed. As described on page 4 of this report, diabetes is diagnosed though blood tests that measure the amount of glucose in the blood. The NYS BRFSS provides information on the proportion of adults who receive the appropriate diagnostic test for diabetes within the past three years.
  • 26. 20 Table 2. Percentage of adults in New York State (NYS) receiving a test for high blood sugar or diabetes in the past three years by selected demographic characteristics, BRFSS 2008-2009 Percent Lower 95% CI Upper 95% CI Age Group All ages 59.8 58.2 61.4 18-44 50.8 48.1 53.5 45-64 68.1 66.0 70.1 65-74 74.7 71.6 77.8 ≥75 68.8 65.2 72.4 Gender Male 58.2 55.5 60.8 Female 61.2 59.3 63.1 Race/Ethnicity Non-Hispanic white 60.5 58.8 62.2 Non-Hispanic black 56.5 50.3 62.8 Hispanic 58.8 52.4 65.1 Non-Hispanic other 54.7 47.5 61.9 Annual Income <$15,000 57.5 51.0 63.9 $15-24,999 59.5 54.4 64.5 $25-34,999 56.6 51.1 62.1 $35-49,999 56.2 51.6 60.7 $50,000 or more 63.4 61.2 65.6 Education <High school 55.4 48.3 62.5 High school or general equivalency diploma 56.7 53.4 59.9 Some post high school 60.6 57.4 63.8 College graduate 62.3 60.0 64.6 Region New York City 60.2 56.8 63.5 NYS (excluding New York City) 59.6 57.8 61.4 In 2008-2009, the self-reported prevalence for having a test for high blood sugar or diabetes in the past three years was 59.8% (95% CI 58.2-61.4%) among NYS adults. The percentage of adults in NYS receiving a test for high blood sugar or diabetes in the past three years does not differ significantly by gender, race/ethnicity, household income, education, or region (New York City vs. rest of state).
  • 27. 18-44 yrs 50.8 45-64 yrs 68.1 65-74 yrs 74.7 75 yrs or older 68.8 All ages 59.8 0 20 40 80 Percent 60 30 50 70 10 21 Figure 12. Percentage of adults in New York State (NYS) receiving a test for high blood sugar or diabetes in the past three years by age, BRFSS 2008-2009 The prevalence of testing for high blood sugar in the past three years is lowest among adults between the ages of 18 to 44 years.
  • 28. Health insurance 62.1 41.5 Regular provider 63.5 37.5 Yes No 0 20 40 60 70 80 Percent 10 30 50 22 Figure 13. Percentage of adults in New York State (NYS) receiving a test for high blood sugar or diabetes in the past three years by access to care indicators, BRFSS 2008-2009 Percent Lower 95% CI Upper 95% CI Insurance Status Have insurance 62.1 60.4 63.7 No insurance 41.5 35.7 47.3 Provider Status Have regular provider 63.5 61.8 65.1 No regular provider 37.5 32.7 42.4 Testing for high blood sugar is less prevalent among adults without health insurance compared to adults who report having health insurance (42% versus 62%) and among adults without a regular healthcare provider compared to adults who report having at least one regular healthcare provider (38% versus 64%).
  • 29. 23 Prediabetes Prediabetes is a condition in which an individual’s blood glucose levels are higher than normal, but not high enough to be diagnosed as diabetes. Like diabetes, prediabetes is detected by means of a blood glucose test. The clinical cut-offs for classification depend on the type of diagnostic test used. The values of these clinical tests that are used to diagnose prediabetes can be found on page 4 of this report. In the United States, an estimated 35% of adults aged 20 or older have prediabetes.9 Adults with prediabetes are 5 to 15 times more likely to develop type 2 diabetes than someone without the condition, and are also at increased risk of developing heart disease, stroke and eye disease.10 Lifestyle intervention programs aimed at increasing physical activity and producing a 5–7% loss of body weight, and certain pharmacological agents have been demonstrated to prevent or delay the development of diabetes in people with prediabetes.11
  • 30. 18-44 yrs 3.4 45-64 yrs 7.5 65-74 yrs 9.4 75 yrs or older 6.4 All ages 5.5 0 15 Percent 5 10 24 Figure 14. Prevalence of prediabetes among New York State (NYS) adults by age, BRFSS 2008-2009 Age (years) Percent Lower 95% CI Upper 95% CI 18-44 yrs 3.4 2.5 4.3 45-64 yrs 7.5 6.3 8.6 65-74 yrs 9.4 7.4 11.4 75 yrs or older 6.4 4.7 8.1 All ages 5.5 4.8 6.1 Prediabetes is less prevalent among adults between the ages of 18 and 44 years (3.4%) than among adults between the ages of 45 to 64 years (7.5%), 65 to 74 years (9.4%), and 75 years or older (6.4%).
  • 31. Non-Hispanic white 5.4 Non-Hispanic black 8.1 Hispanic 3.9 0 8 10 Percent 6 4 2 25 Figure 15. Prevalence of prediabetes among New York State (NYS) adults by race/ethnicity, BRFSS 2008-2009 Race/Ethnicity Percent Lower 95% CI Upper 95% CI Non-Hispanic white 5.4 4.7 6.1 Non-Hispanic black 8.1 4.8 11.4 Hispanic 3.9 2.1 5.8 Self-reported prediabetes does not differ significantly by race/ethnicity.
  • 32. <25 (Neither overweight nor obese) 2.9 25-<30 (Overweight) 5.3 ≥30 (Obese) 10.7 0 10 15 Percent 5 26 Figure 16. Prevalence of prediabetes among New York State (NYS) adults by Body Mass Index (BMI) category, BRFSS 2008-2009 BMI Category Percent Lower 95% CI Upper 95% CI <25 (Neither overweight nor obese) 2.9 2.1 3.8 25-<30 (Overweight) 5.3 4.3 6.3 ≥30 (Obese) 10.7 8.8 12.6 Prediabetes is more prevalent among adults who are obese (10.7%) or overweight (5.3%) than among adults who are neither overweight nor obese (2.9%).
  • 33. 27 Gestational Diabetes Gestational diabetes (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy. Based on this definition, GDM affects approximately 7% of pregnancies in the United States (ranging from 1%-14% depending on the population studied), resulting in approximately 200,000 cases annually.12 Gestational diabetes predisposes women to an increased risk of developing type 2 diabetes later in life, and has been associated with both maternal and fetal adverse health effects including macrosomia, preeclampsia, congenital malformations, and fetal death.13 Because of the health risks gestational diabetes confers to both the mother and infant, public health surveillance of GDM is warranted.
  • 34. Rateper1,000livebirths* 10 30 50 20 40 0 1995 1997 2000 2002 2004 2006 United States New York State 1996 1998 2001 2003 20051998 15 35 25 45 5 28 Figure 17. Prevalence of gestational diabetes in the United States (US) and New York State (NYS), CDC WONDER 1995-200614 Year US Rate New York State Rate 1995 24.7 35.5 1996 25.7 39.5 1997 25.8 40.4 1998 26.0 40.1 1999 26.6 38.4 2000 28.6 42.6 2001 30.5 44.9 2002 32.1 45.0 2003 32.2 43.4 2004 35.1 44.0 2005 37.8 44.1 2006 41.6 47.3 *Based on singleton births, birth certificate change in 2003. More information about this change is available at: http://wonder.cdc.gov/natality.html The prevalence of gestational diabetes in the US and in NYS has gradually increased from 1995 to 2006. The prevalence of gestational diabetes is higher among women in NYS compared to the US overall.
  • 35. Non-Hispanic white 3.8 Non-Hispanic black 4.2 Hispanic 4.1 Non-Hispanic Asian 7.9 Non-Hispanic other 5.0 0 10 Percent 4 6 2 8 29 Figure 18. Prevalence of gestational diabetes in New York State (NYS) by race/ethnicity of mother, NYSDOH Biometrics, 2007 Race/Ethnicity of Mother Percent** Non-Hispanic white 3.8 Non-Hispanic black 4.2 Hispanic 4.1 Non-Hispanic Asian 7.9 Non-Hispanic other 5.0 **No confidence intervals are provided for population-level data In NYS, the prevalence of gestational diabetes is highest among Asian women.
  • 36. 30 References 1 Cowie CC, Rust KF, Fored ES, Eberhardt MS, Dyrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, Geiss LS. Full accounting of diabetes and pre-diabetes in the US population in 1988-1994 and 2005- 2006. Diabetes Care. February 2009;32(2):287- 294. 2 National Institute of Diabetes and Kidney Diseases, National Institutes of Health. Diagnosis of Diabetes, National Diabetes Clearinghouse [cited 2010 Dec 2]. Available at: http://diabetes.niddk.nih.gov/dm/pubs/ diagnosis. 3 American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34(S1):S62-S69. 4 National Diabetes Education Program. Overview of diabetes in children and adolescents. Available at: http://ndep.nih. gov/diabetes/pubs/ Youth_FactSheet.pdf. 5 American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34(S1):S62-S69. 6 National Institute of Diabetes and Kidney Diseases, National Institutes of Health. Diagnosis of Diabetes, National Diabetes Clearinghouse [cited 2010 Jul 19]. Available at: http://diabetes.niddk.nih.gov/dm/pubs/ diagnosis. 7 Centers for Disease Control and Prevention. CDC Wonder Natality Online Database [cited 2010 Jul 19]. Available at http://wonder.cdc. gov/natality.html. 8 Cowie CC, Rust KF, Fored ES, Eberhardt MS, Dyrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, Geiss LS. Full Accounting of Diabetes and Pre-Diabetes in the US Population in 1988-1994 and 2005- 2006. Diabetes Care. February 2009;32(2):287- 294. 9 Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2011. 10 Cited in Centers for Disease Control and Prevention, Diabetes Public Health Resources. Frequently Asked Questions about Pre-Diabetes [cited 2009 Jun 1]. Available at: http://www.cdc.gov/diabetes/ faq/prediabetes.htm. 11 American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34(S1):S62-S69. 12 American Diabetes Association. Standards of medical care in diabetes. – 2011. Diabetes Care. 2011:34(S1):S11-S61. 13 Vincor, F. Diabetes & women’s health across the life stages: A public health perspective. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2001 [cited 2010 Feb 19]. Available at: http://www.cdc.gov/diabetes/ pubs/pdf/womenshort.pdf 14 United States Department of Health and Human Services (US DHHS), Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), Division of Vital Statistics, Natality public-use data 1995-2006, on CDC WONDER Online Database, March 2009 [cited 2009 Dec 23]. Available at: http://wonder.cdc.gov/natality- current.html.
  • 37.
  • 38. State of New York Department of Health 10/11